Vertiv (VRT -0.30%), a provider of thermal management, liquid cooling, and uninterruptible power supply (UPS) systems for data centers, attracted a stampede of bulls in the first half of 2026 as the AI market's growth boosted its sales and margins. Its stock closed at a record high of $376.06 per share on May 14, marking a 2,390% gain over its previous three years.
But today, Vertiv's stock trades at about $211. Let's see why it pulled back, and whether it will recover and set fresh highs over the next 12 months.
Image source: Getty Images.
How fast is Vertiv growing? The AI market's rapid expansion is driving more data centers to upgrade their servers with Nvidia's (NVDA +1.54%) latest GPUs and other AI chips. However, those new chips consume so much power and generate so much heat that data centers must upgrade their infrastructure with Vertiv's cooling products and UPS systems to operate safely and efficiently.
From 2021 to 2025, Vertiv's revenue more than doubled from $5.0 billion to $10.2 billion, while its adjusted EPS rose more than fivefold from $0.76 to $4.20. Its backlog reached $15 billion at the end of the second quarter of 2026.
For 2026, Vertiv expects its revenue to rise 37% (31% organically) to $14 billion, and for its adjusted EPS to grow 60%. It trades at 31 times that earnings estimate.
VRT Vertiv$205.81-$0.61 (-0.30%)
NYSE · As of 2:36 PM ET 10/19/26
Why did Vertiv's stock pull back? Three challenges weighed down Vertiv's stock over the past five months. First, it slightly missed Wall Street's aggressive top-line estimates for the second quarter, due to the lumpy timing of its larger contracts and supply chain constraints.
Second, Vertiv agreed to acquire UtilityInnovation Group -- a developer of microgrid solutions, advanced power controls, and behind-the-meter power architecture designs for data centers -- for $1.45 billion in cash in February. The integration of that deal, expected to close in the fourth quarter, could affect its near-term margins. Lastly, rising interest rates broadly compressed the valuations of higher-growth AI stocks.
Analysts expect Vertiv's adjusted EPS to grow 60% in 2026 and 36% in 2027. If it matches those expectations and still trades at 30 times its current year's earnings by next October, its stock could rally about 30% to $276 per share over the next 12 months.
That would fall short of its all-time high, but it could still head much higher over the next few years as the data center market expands. Therefore, its recent pullback could be a great buying opportunity for investors seeking exposure to the AI infrastructure market.
Klíčovou zkouškou pro Arista Networks bude výhled tržeb na čtvrté čtvrtletí: Wall Street očekává tržby ve výši 3,6 miliardy USD a čistý zisk 1,15 USD na akcii.
Arista Networks (ANET +3.22%) is scheduled to report third-quarter earnings on Nov. 3, but I think the most important numbers in the report won't have anything to do with the third quarter.
Instead, I'll be watching what management says about the final three months of 2026.
According to Yahoo Finance, Wall Street expects the artificial intelligence (AI) networking company to generate $3.6 billion in fourth-quarter revenue and earnings of $1.15 per share. Those are some pretty ambitious targets, but I think Arista has a good chance to exceed them.
And if management delivers guidance that beats those expectations, I think Arista stock could soar after Nov. 3.
Image source: Getty Images.
Why fourth-quarter guidance matters
Arista has become an important supplier of the high-speed networking equipment that connects processors and servers inside massive artificial intelligence data centers.
Companies such as Nvidia are developing increasingly powerful graphics processing units (GPUs), but those chips can't reach their full potential unless enormous amounts of information can move between them quickly.
Arista makes Ethernet switches that help eliminate networking bottlenecks, allowing thousands of processors to work together on demanding AI applications.
The company reported second-quarter revenue of $3.03 billion, a 37.7% increase from a year ago. Diluted earnings per share reached $0.95, compared with $0.70 in the year-earlier period. Management also projected third-quarter revenue of approximately $3.3 billion.
That's in line with what Wall Street projects. According to Yahoo Finance, the consensus Q3 estimates are $3.33 billion in revenue and $1.08 in earnings per share (EPS).
I'm not too worried about Q3 results -- instead, I'd rather look ahead. Investors already know that Arista is growing quickly. What they need to know now is whether demand for their networking equipment will remain strong as cloud computing companies continue to expand their AI infrastructure.
That's why fourth-quarter guidance could be more important than the third-quarter results themselves.
$182.68+$5.70 (+3.22%)
NYSE · As of 2:33 PM ET 10/19/26
Arista's path to topping Wall Street expectations
Arista has been introducing new networking products designed to handle increasingly demanding AI workloads.
Its 7060XE7 platform supports connections running at 1.6 terabits per second, while its recently announced Etherlink SU-144 architecture can connect up to 144 AI accelerators within a single-hop network.
Those capabilities are becoming more important as AI data centers grow larger and companies look for ways to get more performance from their expensive processors.
The opportunity is substantial, but so is the competition. Nvidia and Cisco Systems are also pursuing the AI networking market, and Arista depends heavily on spending by major cloud computing companies. Still, I think the company's recent growth gives management a reasonable opportunity to surprise Wall Street.
Arista typically provides quarterly revenue and margin guidance rather than an explicit earnings-per-share forecast. So I'll be watching whether its fourth-quarter revenue outlook exceeds $3.6 billion and whether its projected profitability supports earnings above the $1.15 consensus estimate.
A revenue forecast above expectations would suggest that demand for Arista's networking equipment remains stronger than Wall Street anticipated. Healthy margins would make that growth even more valuable to shareholders.
Calix (CALX) rozšířil platformu Agent Workforce o Control Center a nové pracovní postupy založené na AI; připravované Workflow Studio umožní poskytovatelům upravovat automatizaci bez programování.
New Control Center for Calix Agent Workforce gives service providers one secure, personalized workspace to put purpose-built AI to work across their business while keeping humans in control. Expanded workflows help teams accelerate growth, strengthen loyalty, and streamline operations, while upcoming Workflow Studio will let providers tailor AI workflows to their unique business needs.
SAN JOSE, Calif.--(BUSINESS WIRE)--Today, at its annual innovation and customer success conference, Calix, Inc. (NYSE: CALX) delivered advancements for Calix Agent Workforce™ on the Calix One™ platform, giving service providers greater control over how AI operates within their workflows, more ways to put it to work, and flexibility to tailor it to their unique business needs—all while keeping humans at the helm.
"For 26 years, we have innovated with service providers, not for them. And over the past 15 years, we have invested more than $2 billion evolving the platform that enables Agent Workforce to put that expertise to work," said Calix CEO Michael Weening.
Share Unlike generic AI tools that service providers must adapt to their businesses, Agent Workforce is purpose-built for how they operate. Powered by the AI-native Calix One platform, which processes a petabyte of data daily, Agent Workforce draws on decades of domain expertise to combine network intelligence, subscriber context, and real-world provider workflows with the trust and orchestration needed to put AI to work. This foundation moves service providers beyond isolated tools toward a unified AI workforce that human teams can manage from one place, leverage to act on insights, deploy across more business functions, and tailor to their unique business needs.
Calix is expanding Agent Workforce with three innovations:
Launching: Control Center brings Agent Workforce into a single personalized operating experience. Personalized by role and permissions, Control Center gives marketing, service, and operations teams one conversational workspace to understand, direct, and act on AI-driven insights and workflows across their business. Teams can surface acquisition opportunities, get subscriber context to address service needs, or investigate network issues—putting the right intelligence and actions in the hands of the right people at the right time. Launching: Expanded AI workflows extend purpose-built capabilities across more of the business. New AI-powered workflows help teams identify more growth opportunities, automate marketing campaigns, engage subscribers across more channels, investigate network health alerts, identify emerging outages, and more. These build on workflows introduced in September that help service providers uncover more upsell opportunities and resolve subscriber issues faster. By applying network and subscriber intelligence to a growing range of business challenges, Agent Workforce reduces manual effort and improves operational efficiency. Coming soon: Calix Workflow Studio will let service providers adapt AI to how they operate. Building on ready-to-use Agent Workforce capabilities, the planned no-code Workflow Studio will enable teams to tailor workflows to their business needs by connecting agents, data, tools, and existing systems. Planned support for open standards, including A2A and MCP, will give service providers greater flexibility to extend automation across their business and partner ecosystem. Calix Success™ helps service providers turn secure AI capabilities into measurable business value through expert guidance, education, and proven best practices. The Calix AI Leadership Playbook gives teams a strategic framework to move beyond generic AI experimentation and to operationalize agentic AI across their businesses. Calix Success also helps providers identify high-value opportunities, integrate Agent Workforce into everyday operations, and build organizational readiness to scale adoption.
Scott Hendrix, chief executive officer at Tombigbee Fiber and Tombigbee Electric Power Association, said: “For us, AI isn’t about replacing people. It’s about giving our teams the tools and knowledge to do more for the members we serve. With Calix Agent Workforce, we’re already seeing how our employees can learn faster, work through complex issues, and better understand what our members need. As we bring these capabilities into more of our daily operations, I see tremendous opportunity to make our team more effective, deliver better service, and grow our business without losing the personal connection that makes Tombigbee special.”
Michael Weening, president and chief executive officer at Calix, said: “AI won’t replace companies, but companies who use AI will replace those who do not. Today, that is truer than ever. For 26 years, we have innovated with service providers, not for them. And over the past 15 years, we have invested more than $2 billion evolving the platform that enables Agent Workforce to put that expertise to work. Control Center scales the expertise of their people so they can move faster, while Workflow Studio will enable them to adapt and extend purpose-built workflows to what makes their business unique. We thank every customer who continues on this journey with us. The game is on, and we are excited to help them use AI to compete and win.”
Discover how Calix Agent Workforce, powered by the AI-native Calix One platform, helps service providers drive subscriber growth, strengthen loyalty, and streamline operations.
About Calix
Calix, Inc. (NYSE: CALX) is an AI platform company that enables service providers to transform their operations and accelerate delivery of differentiated experiences—so they can compete and win in the markets and communities they serve.
Through the AI-native Calix One platform, service providers can securely and privately activate agentic AI alongside their human teams to acquire new subscribers, grow existing subscriber revenue, and build loyalty across residential, business, municipal, and MDU markets. More than 1,200 customers of all sizes leverage the Calix One platform, which has evolved over 15 years at an investment of more than $2 billion.
Calix innovation cycles are underpinned by a strong financial balance sheet and a people‑first culture that routinely earns broad industry recognition—winning 81 culture and innovation awards since 2025 alone, as well as Fortune’s 100 Best Companies to Work For® in 2026.
This press release contains forward-looking statements that are based upon management’s current expectations and are inherently uncertain. Forward-looking statements are based upon information available to us as of the date of this release, and we assume no obligation to revise or update any such forward-looking statement to reflect any event or circumstance after the date of this release, except as required by law. Actual results and the timing of events could differ materially from current expectations based on risks and uncertainties affecting Calix’s business. The reader is cautioned not to rely on the forward-looking statements contained in this press release. Additional information on potential factors that could affect Calix’s results and other risks and uncertainties are detailed in its quarterly reports on Form 10-Q and Annual Report on Form 10-K filed with the SEC and available at www.sec.gov.
Calix and the Calix logo are trademarks or registered trademarks of Calix and/or its affiliates in the U.S. and other countries. A listing of Calix’s trademarks can be found at https://www.calix.com/legal/trademarks.html. Third-party trademarks mentioned are the property of their respective owners.
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Headquartered in Redwood City, Equinix (EQIX - Free Report) is a Finance stock that has seen a price change of 28.69% so far this year. Currently paying a dividend of $5.16 per share, the company has a dividend yield of 2.09%. In comparison, the REIT and Equity Trust - Retail industry's yield is 4.45%, while the S&P 500's yield is 1.38%.
Looking at dividend growth, the company's current annualized dividend of $20.64 is up 10% from last year. Over the last 5 years, Equinix has increased its dividend 5 times on a year-over-year basis for an average annual increase of 13.62%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Equinix's current payout ratio is 50%, meaning it paid out 50% of its trailing 12-month EPS as dividend.
Looking at this fiscal year, EQIX expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $43.45 per share, representing a year-over-year earnings growth rate of 13.36%.
Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. However, not all companies offer a quarterly payout.
High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, EQIX is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).
COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, announced today that it is seeking to increase its outstanding ~$500 million Term Loan B by $250 million (“Add-On”). Net proceeds from the Add-On are expected to be used for general corporate purposes and to pay associated fees.
We expect the Add-On to have the same terms as our existing Term Loan B. The proposed increase is subject to market and other conditions, and there can be no assurance that it will be completed.
The lender presentation will be posted to the investor relations section of our website on October 19, 2026.
About Installed Building Products
Installed Building Products, Inc. is one of the nation's largest new residential insulation installers and is a diversified installer of complementary building products, including waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors and other products for residential and commercial builders located in the continental United States. The Company manages all aspects of the installation process for its customers, from direct purchase and receipt of materials from national manufacturers to its timely supply of materials to job sites and quality installation. The Company offers its portfolio of services for new and existing single-family and multi-family residential and commercial building projects in all 48 continental states and the District of Columbia from its national network of over 250 branch locations.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, including with respect to the proposed expansion of the Company's existing Term Loan B facility, the anticipated size, terms, and completion of the transaction, and the intended use of proceeds, the housing market and the commercial market, our operations, industry and economic conditions, our financial and business model, the demand for our services and product offerings, expansion of our national footprint and end markets, diversification of our products, our ability to grow and strengthen our market position, our ability to pursue and integrate value-enhancing acquisitions, our ability to improve sales and profitability, and expectations for demand for our services and our earnings. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intends," "plan," and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Any forward-looking statements that we make herein and in any future reports and statements are not guarantees of future performance, and actual results may differ materially from those expressed in or suggested by such forward-looking statements as a result of various factors, including, without limitation, the ability to successfully complete the proposed expansion of the Term Loan B facility on anticipated terms or at all; changes in market conditions that could affect the proposed transaction; general economic and industry conditions; increases in mortgage interest rates and rising home prices; inflation and interest rates; the material price and supply environment; increased tariffs; the timing of increases in our selling prices; and the factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as the same may be updated from time to time in our subsequent filings with the Securities and Exchange Commission. Any forward-looking statement made by the Company in this press release speaks only as of the date hereof. New risks and uncertainties arise from time to time, and it is impossible for the Company to predict these events or how they may affect it. The Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws.
FTC a další úřady žalují společnost Hims & Hers kvůli údajnému klamání spotřebitelů a sdílení zdravotních údajů; akcie 29. července 2026 klesly o 14,73 % na 25 USD.
NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 22025,and July 29, 2026 (the "Class Period").
Investors who purchased Hims & Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026.
PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION
The filed complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failing to disclose material adverse facts to investors, including that
the Company shared consumers' health information with third-party advertising platforms;
the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them;"
the foregoing conduct subjected the Company to regulatory scrutiny;
because of the foregoing, the Company was reasonably likely to incur fees and penalties; and
because of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On July 29, 2026, the Federal Trade Commission ("FTC"), the People of the State of California through Los Angeles County Counsel and the Utah Division of Consumer Protection sued Hims & Hers in the Northern District of California. According to the FTC, the action alleges that Hims & Hers fails to clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find treatment that is "right for them." The FTC also alleges that the company has made it difficult for consumers to cancel subscriptions and misled consumers about keeping their health information private. The FTC alleges that Hims shared consumers' health information with Meta, Snap and other third parties.
Following this news, the price of Hims & Hers stock fell $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.
WHY WOLF HALDENSTEIN?
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
There is no cost or obligation to speak with an attorney.
Contact:
Phone: (800) 575-0735 or (212) 545-4774Email: [email protected] Person: Gregory Stone, Director of Case and Financial Analysis Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Akcie Trump Media intradenně klesly o 7 % na 6,48 USD, zatímco Rumble vzrostl o 3 %. Ve 2. čtvrtletí vykázala Trump Media čistou ztrátu 238,1 milionu USD.
Trump Media stock is sliding hard on a day when nearly everything else is climbing, and the reason has less to do with the broader market than with what sits inside the company's own balance sheet and merger pipeline.
One alternative social media name is slipping while its closest rival rises, a split that marks the selling as company-specific. Trump Media & Technology Group (NASDAQ:DJT) stock has fallen 7% to $6.48 this afternoon.
Meanwhile, Rumble (NASDAQ:RUM) shares are up 3% to $5.87, a move that runs opposite to Trump Media stock. Inside Trump Media sit the Truth Social platform, the Truth+ streaming service and the Truth.Fi financial brand, while Rumble runs a video-sharing site for content creators. Shares of both Trump Media and Rumble trade on Nasdaq, and the pair often get grouped as alternative social media peers.
Trump Media Breaks From Its Benchmarks
A look at large-cap benchmarks shows how isolated the drop in Trump Media stock is. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 0.6%, a gain that leaves Trump Media stock moving against the large-cap tide.
Sector-level trading shows the same split for Trump Media stock, with the Global X Social Media ETF (NASDAQ:SOCL) up 0.3%. Trump Media stock made up just 0.7% of the fund’s net assets as of July 31, while Rumble shares accounted for 0.3%, so neither stock carries much weight in SOCL’s move.
TAE Merger Approvals Remain Pending
TAE Technologies, a privately held fusion energy developer, and Trump Media filed a registration statement in late September for their planned all-stock merger. The deal still needs shareholder and regulatory approvals, and Trump Media has targeted completion in Q4 2026, subject to standard closing conditions.
Management at Trump Media views the TAE transaction as a strategic extension into energy security infrastructure. In the Q2 2026 earnings release, Chief Executive Kevin McGurn called the merger “the most important driver of long-term shareholder value and a natural extension of our commitment to building durable, un-cancellable infrastructure, this time in energy security.”
Digital Asset Losses Shape the Results
Trump Media’s core operations remain small next to its losses. Q2 revenue came in at $1.7 million, up 92.5% from a year earlier, against a net loss of $238.1 million. Of that total, $190.4 million came from Trump Media’s non-cash unrealized losses on digital assets and equity securities.
On the balance sheet, Trump Media held $1.9 billion in financial holdings, spanning cash, digital assets, equity securities and short-term investments. That mix leaves Trump Media stock sensitive to swings in digital asset prices. Newer products add some balance, with Truth API launching on August 1 and signing more than 10 customer agreements while Truth+ reached full commercial availability.
Legal costs added to the pressure on Trump Media, with Q2 expenses of $25.6 million tied mostly to legacy litigation. Its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) loss widened to $223.5 million from $12.8 million in the prior-year quarter. Management expects legal expenses to decline significantly and plans a more strict framework for managing the company’s digital asset treasury.
Merger Approvals Hold the Key for Trump Media
The open variable for Trump Media is whether the TAE merger clears its shareholder and regulatory approvals. Completion could give Trump Media a position in fusion energy alongside Truth Social, while delays could keep Trump Media stock tied mostly to its digital asset treasury. Investors can watch for whether Trump Media’s balance sheet holds steady as digital asset prices swing.
A drop of this scale against a rising market shows how quickly Trump Media stock can move on its own, even as Rumble shares, SOCL and SPY climb. Trump Media’s next quarterly report could show whether Truth API revenue builds on its early customer agreements. Traders may choose to reduce their DJT stock exposure until the TAE merger approvals resolve.
Contact [email protected] for any questions or corrections.
Metis TechBio uzavřela s Eli Lilly spolupráci na vývoji cíleného doručování léčiv. Metis může získat zálohovou platbu v nízkých desítkách milionů USD a až zhruba 1,1 miliardy USD ve formě vývojových, regulačních a obchodních milníkových plateb.
Oct 19 (Reuters) - Hong Kong-listed Metis TechBio 7666.HK said on Monday it has entered into a collaboration agreement with Eli Lilly LLY.N worth up to $1.1 billion to research and develop tissue-specific drug delivery technologies.
The Chinese biotech will use its proprietary AI-driven drug-delivery platform to develop next-generation technologies aimed at improving how LNP-based drugs reach target tissues.
Metis will be eligible to receive an upfront payment in the low double-digit millions US dollars and up to about $1.1 billion in development, regulatory and commercial milestone payments.
It will also be eligible for tiered royalties at a single-digit percentage of annual net sales of products that are developed due to the collaboration.
The Chinese biotech will use its proprietary AI-driven ionizable lipid discovery and optimisation platform to develop delivery technologies aimed at improving the targeting and biodistribution of LNP-based therapies.
Metis and Lilly aim to discover and optimise novel LNP architectures that could improve tissue specificity and therapeutic performance, with potential applications across multiple disease areas.
(Reporting by Nikita Maria Jino and Kumar Tanishk in Bengaluru; Editing by Joyjeet Das)
GBP/USD po silném týdenním obratu od spodní hranice pásma míří k otestování úrovní 1,3650–1,3675; nejbližší klíčová rezistence se nachází u 1,3435, kde leží 200denní klouzavý průměr.
Scotiabank strategists Shaun Osborne and Eric Theoret note GBP/USD is little changed as markets await UK labour data, Consumer Price Index (CPI) and next week’s budget, where investors expect Chancellor Healey to maintain fiscal discipline. Technically, the British Pound (GBP) has staged a strong bullish weekly reversal from the lower end of its sideways range, with scope to retest 1.3650/75 and initial resistance at the 200-day moving average near 1.3435.
Pound eyes retest of range top
"The GBP is little changed on the session. Spot is marking time ahead of tomorrow’s jobs and wage, with CPI released on Wednesday."
"Next week’s budget is starting to attract a little attention as well, with local reports suggesting that investors are banking on Chancellor Healey maintaining a steady hand on spending and borrowing to boost Gilts."
"Bullish – Solid GBP gains from Wednesday’s post-US CPI low drove a huge bullish weekly reversal on the chart (outside range week)."
"Follow through demand so far has been limited but the scale of last week’s rebound from the weekly low and net gain is hard to ignore."
"With recent price action basing around the low point of the sideways range in place since April, the pound’s solid gain last week should put spot on course to retest the upper end of the range (1.3650/75) in the coming weeks."
"Initial, key resistance sits at 1.3435 (200-day MA)."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor. Know more.)
Akcie CoreWeave (CRWV) za poslední měsíc klesly o více než 27 %; autor zvýšil své hodnocení na „Strong Buy“ kvůli ocenění na úrovni 10,6násobku očekávaného ukazatele EBITDA.
SummaryCoreWeave, Inc. has sold off sharply, but I'm upgrading to a Strong Buy, as de-risking appears overdone and risk-reward is now favorable.Despite credit market stress and sector-wide AI bubble fears, CRWV’s deep Nvidia relationship and large backlog support my investment thesis.Valuation is compelling: CRWV trades at 10.6x forward EBITDA, a steep discount to peers, already pricing in much of the financing risk.If CRWV converts backlog to revenue and secures cheaper, contract-backed funding, financing fears should fade and upside potential remains strong. Richard ODonoghue/iStock via Getty Images
CoreWeave, Inc. (CRWV) led the AI selloff last week. The stock is now down over 27% over the past month, 48% over the past 6 months, and another 14% year to date. This selloff looks almost identical
5.55K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Projekt Skouries společnosti Eldorado Gold získal od Evropské komise status strategického projektu EU pro kritické suroviny. Důl v Řecku má po dobu 20 let průměrně produkovat 240 000 uncí ekvivalentu zlata ročně.
Key Takeaways EGO's Skouries in northern Greece receives Strategic Project designation from the European Commission.The move supports EU efforts to boost domestic critical raw materials supply and reduce external dependence.Skouries targets 240,000 gold-equivalent ounces annually over its 20-year mine life.
Eldorado Gold Corporation (EGO - Free Report) announced that its Skouries copper-gold asset in northern Greece received a Strategic Project designation from the European Commission under the EU’s Critical Raw Materials Act. This underscores the Skouries project’s strategic significance in strengthening Europe’s long-term supply-chain resilience. The designation also highlights the project’s importance in supporting the EU’s efforts to strengthen domestic supply chains for critical raw materials.
The EU adopted the European Union’s Critical Raw Materials Act to solidify the region’s access to critical raw materials and lower dependence on external sources of supply. The Act selects Strategic Projects post assessing their potential contribution to European supply security, technical feasibility and sustainability standards.
Details on Eldorado Gold’s Skouries MineSkouries is located in the Halkidiki region of northern Greece and is expected to become a significant producer of both copper and gold over its 20-year mine life. The mine is expected to produce an average 240,000 gold-equivalent ounces annually over the life of the mine.
In late September, the company announced that the mine has been successfully energized following necessary approvals. This was essential in advancing Skouries toward ramp-up to steady-state operations. This, along with the recent achievement of first copper-gold concentrate production, reflects strong execution at the mine as the company continues to advance it toward commercial production.
EGO’s Q2 PerformanceEldorado Gold reported adjusted earnings of 54 cents per share for the second quarter of 2026, up from earnings of 44 cents a year ago. The figure beat the Zacks Consensus Estimate of 52 cents by 3.85%. The company reported revenues of $488 million compared with $452 million in the year- ago quarter. It produced 104,616 ounces of gold during the second quarter of 2026.
The company belongs to the Zacks Mining – Gold industry, along with Royal Gold, Inc. (RGLD - Free Report) , Franco-Nevada Corporation (FNV - Free Report) and B2Gold Corp. (BTG - Free Report) . Let us see how BTG’s peers performed in the second quarter of 2026.
Royal Gold reported adjusted earnings of $2.56 per share for the second quarter of 2026, up 41.4% from $1.81 a year ago. The figure missed the Zacks Consensus Estimate of $2.62 by 2.29%. Royal Gold’s revenues surged 114.9% year over year to $450.5 million, aided by higher metal prices, new contributions from Kansanshi and the Sandstorm/Horizon assets, and stronger gold sales at Andacollo and Rainy River. Sales volume rose 56.5% to 100,000 gold-equivalent ounces.
Franco-Nevada reported adjusted earnings of $1.81 per share in the second quarter of 2026, up 46% year over year. However, the bottom line missed the Zacks Consensus Estimate of $1.95. Franco-Nevada’s revenues climbed 57.3% year over year to $581 million, aided by stronger precious metal and oil prices, and higher contributions from several assets. Gold-equivalent ounces sold increased 18.1% to 132,405.
B2Gold reported adjusted earnings of 3 cents per share for the second quarter of 2026, missing the Zacks Consensus Estimate of 7 cents by 57.14%. The bottom line fell 75% from 12 cents in the year-ago quarter. Adjusted earnings included $71 million of realized losses on the company’s gold collars. B2Gold generated revenues of $789 million in the second quarter of 2026, reflecting a year-over-year increase of 14%. The upside was supported by higher realized gold prices, with the average realized gold price rising to $3,767 per ounce from $3,290 in the prior-year quarter, partly offset by a slight decline in gold ounces sold to 209,537 from 210,384.
Shares of Sandisk (SNDK +6.05%) charged sharply higher on Monday, jumping as much as 8.3%. As of 11:24 a.m. ET, the stock was still up 7.9%.
While a rebound in technology issues certainly helped, the semiconductor specialist rallied on positive news in the high-bandwidth memory (HBM) space.
Image source: The Motley Fool.
Industry standardEarlier this year, Nvidia (NVDA +1.78%) announced the development of NVHBM, the company's custom HBM architecture. NVHBM is a custom HBM die that delivers 15% lower power consumption and 30% higher bandwidth, all on a smaller die than HBM4e. To be clear, this isn't a replacement for traditional HBM, but rather connective technology between Nvidia's NVLink and HBM chips.
A report emerged over the weekend that Nvidia has asked Samsung Electronics to adopt Taiwan Semiconductor Manufacturing's 3-nanometer chipmaking process to produce the NVHBM dies, according to a story that first appeared in the Seoul Economic Daily. This will mark the first such collaboration between TSMC and Samsung, according to the report.
SNDK Sandisk$1,377.94+$78.64 (+6.05%)
NASDAQ · As of 1:27 PM ET 10/19/26
Moreover, Nvidia has approached the industry's biggest memory producers, including Micron Technology and SK Hynix, to use this process, which would standardize it across multiple memory suppliers. This, in turn, would free up valuable real estate on the compute die, resulting in up to 30% additional compute.
Investors have been concerned that demand for artificial intelligence (AI) could falter, thereby reducing demand for the AI chips. This move by Nvidia suggests that -- despite fears to the contrary -- the adoption of AI still has room to run. This suggests that the same is true for memory chip suppliers.
Even in the face of unprecedented demand for memory chips, Sandisk stock is selling for just 19 times earnings and 6 times forward earnings. This gives investors the opportunity to pick up shares at a discount.
Danny Vena, CPA has positions in Micron Technology, Nvidia, and Sandisk. The Motley Fool has positions in and recommends Micron Technology, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.
Apple 28. října uspořádá produktovou akci zaměřenou na zařízení řady Pro; analytik společnosti Melius Research očekává letos na podzim nové Macy, včetně notebooku s dotykovým displejem.
Apple announced a product launch event on Oct. 28, sending invitations on Monday to media and analysts for an "Apple Experience in Los Angeles".
The email says "Pro and tell," suggesting the launch will focus on high-end "Pro" devices with powerful homegrown chips.
Ben Reitzes, an analyst at Melius Research, wrote in a note on Monday that he expects new Macs to be introduced, "including a touchscreen notebook," this fall. He said that for CEO John Ternus, who succeeded Tim Cook last month, the launch cadence marks a "meaningful shift" from what has been two events a year.
It will be Apple's third launch in Ternus' brief tenure, following an event at company headquarters for new iPhones, including the foldable Duo, and a gathering in New York centered around smart home hubs and a new speaker with a screen called HomeView.
Apple updated its Mac Mini and Mac Studio desktops with new chips in August, and refreshed its MacBook Pro in the spring, along with a new low-cost MacBook Neo. But Apple's iMac desktop hasn't been updated since October 2024.
In the most recent quarter, Apple's Mac sales accounted for about 10% of overall revenue, as the company remains heavily reliant on iPhones.
Still, Macs have become one of the strongest parts of Apple's artificial intelligence story, thanks to its chips that can access more memory at higher speeds than other consumer processors. Apple shares are up 26% so far this year, outperforming the S&P 500.
Last week, Apple and Meta teamed up to bring a large open-weight model, developed by Meta, to multiple high-end Mac Studios.
Apple has historically been dismissive of touchscreen laptops, with software chief Craig Federighi explaining in 2018 that the ergonomics would fatigue users.
Akcie společnosti Tesla v odpoledním obchodování vzrostly o 4 % na 367,59 USD poté, co guvernér Floridy Ron DeSantis slíbil ve státě legalizovat létající Roadster.
Florida's governor just made a bold promise about Tesla's flying Roadster, and the stock market is already reacting in ways that separate Tesla from every other EV maker on the board.
A pledge from Florida’s governor is lifting one electric vehicle maker while its smaller rivals retreat. Tesla (NASDAQ:TSLA | TSLA Price Prediction) shares are up 4% to $367.59 in afternoon trading after Florida Governor Ron DeSantis promised to make the company’s flying Roadster legal in his state.
Meanwhile, Rivian Automotive (NASDAQ:RIVN) shares are down 0.9% to $12.31, trailing well behind the gain in Tesla shares, and Lucid Group (NASDAQ:LCID) is off by 1.12% to $3.10.
The divergence points to a reaction to the Roadster headline that’s specific to Tesla, and Rivian and Lucid are smaller pure-play EV makers that aren’t yet profitable.
DeSantis Pledges Florida Will Make the Roadster Legal
Florida Governor Ron DeSantis took to X. He declared that his state will make Tesla’s flying Roadster legal, writing, “We will make sure that it’s legal.” His comments followed Tesla’s revealing of the long-delayed Roadster last week.
At that event, a version of the Roadster fitted with air tanks and thrusters launched off a ramp, flew briefly and landed on its wheels. The demonstration turned a sports car Tesla has promised for years into a showcase for its engineering ambitions, and the governor’s pledge now adds a political boost.
Tesla stock is also rising alongside a broad rebound in technology names, so the Roadster headline is one of two forces behind the move. Large-cap tech is strong, with the Invesco QQQ Trust (NASDAQ:QQQ) up 2%. That gap with Tesla stock suggests the Roadster pledge is giving Tesla an extra boost on top of the tech rally.
Tesla Pulls Away From Rivian and Lucid
The Global X Autonomous & Electric Vehicles ETF (NASDAQ:DRIV) is up 1%, a smaller advance than Tesla shares are posting. Its portfolio spans automakers, chipmakers, battery suppliers and autonomy software firms, which reduces the effect of any headline about a single company.
Rivian builds the R1T pickup, the R1S SUV and commercial electric delivery vans, and it’s launching the mid-size R2 SUV to reach a broader market. Lucid designs the Air sedan and the Gravity SUV, assembling them in Arizona while preparing a second plant in Saudi Arabia for production. A software and services section, including a joint venture with Volkswagen Group, gives Rivian another source of revenue.
Closer to the governor’s home state, Tesla runs its Robotaxi service in several U.S. metros, including unsupervised rides in Miami, Orlando and Tampa. That Florida presence gives the governor’s endorsement extra weight for Tesla. Cybercab production has also begun at Tesla’s Gigafactory Texas, and lines for the Optimus humanoid robot are being installed.
Roadster Hype Meets Regulatory Reality
Federal regulators decide whether a vehicle can fly, so Florida’s endorsement carries mostly symbolic weight, and production isn’t expected for years while Tesla hasn’t announced a price for the flying version.
Optimists see the Roadster as evidence Tesla can still generate excitement around new hardware. However, a vehicle years from production and lacking federal clearance may add little to Tesla’s near-term results. Tesla’s growth pitch already leans on Full Self-Driving software, Megapack batteries and the Robotaxi service, leaving the Roadster at its edge.
Washington Holds the Key to the Flying Roadster
The next test for Tesla is whether the flying Roadster ever clears federal approval. Shareholders can watch for whether Florida officials follow up with details on how the state intends to honor the governor’s pledge.
A rally in Tesla shares while Rivian and Lucid shares are slipping shows the Roadster headline lifting a single name in the EV group. Traders may prefer to keep their TSLA stock exposure reasonably small. It’s wise to do so until the flying Roadster’s path to production resolves, the kind of fenced-off speculation we spelled out in a free guide to small-stakes bets.
Contact [email protected] for any questions or corrections.
Amazon is funding development of a proposed 960-megawatt nuclear plant in Indiana and would be the first customer to buy its power, the companies announced Monday. Utility company American Electric Power (AEP) would operate the plant. X-energy, which designs small modular nuclear reactors and went public in April, would supply the reactors.
The new power plant would consist of 12 Xe-100 small modular reactors and be located on the site of a demolished coal power plant just south of Terre Haute. The deal is the second commercial agreement between Amazon and X-energy, and it’s three times larger than the first, which was announced two years ago.
Amazon has invested heavily in X-energy, leading a $700 million Series C-1 round in October 2024. The two companies have said they ultimately plan to build 5 gigawatts of new nuclear generating capacity in the U.S. by 2039.
Unlike many newly announced power plants, these reactors would be connected to the public electric grid, though Amazon says the power would also serve its data centers.
The companies’ aggressive timeline still depends on X-energy successfully delivering its first power plant at a Dow Chemical plant southeast of Houston, Texas. The site, called Seadrift, has recently been at the center of a lawsuit filed by the state of Texas, which accuses the plant of “habitual non-compliance” with water and solid-waste regulations and permits.
X-energy has yet to break ground at Seadrift, which will host four Xe-100 reactors to provide the chemical plant with heat and electricity. The company said its construction permit is in the final phases of the U.S. Nuclear Regulatory Commission’s review process.
Startups and large cloud computing companies are betting that small modular reactors (SMRs), like the kind being developed by X-energy, will help pull the nuclear industry out of its slump. The most recent nuclear power plants built in the U.S. suffered from egregious budget overruns and slipped timelines.
By shrinking the reactor, companies like X-energy hope that mass manufacturing will costs and schedules in line. Even then, it could be a tall order. Experts say mass manufacturing often doesn’t start producing benefits for about a decade.
X-energy debuted on the Nasdaq in April in an IPO priced at $23 per share. Investor excitement drove the price up 27% in the first day of trading, but shares of the newly public company have dropped by nearly two-thirds since then.
News of the Amazon deal sent X-energy’s shares up about 10% in pre-market trading, though they were down by less than 2% at the time of publication.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Tim De Chant is a senior climate reporter at TechCrunch. He has written for a wide range of publications, including Wired magazine, the Chicago Tribune, Ars Technica, The Wire China, and NOVA Next, where he was founding editor.
De Chant is also a lecturer in MIT’s Graduate Program in Science Writing, and he was awarded a Knight Science Journalism Fellowship at MIT in 2018, during which time he studied climate technologies and explored new business models for journalism. He received his PhD in environmental science, policy, and management from the University of California, Berkeley, and his BA degree in environmental studies, English, and biology from St. Olaf College.
You can contact or verify outreach from Tim by emailing [email protected].
A Reddit trader claims he rode an AMD position all the way to $16 million, then cashed out completely, convinced the market had finally broken. Now the question is whether he read the signs right or walked away from something…
A trader on Reddit’s r/wallstreetbets says he turned an Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) position into a fortune, then sold all of it. On October 16, 2026, user DubiousChemistry posted “+$16,000,000 on AMD and SOXL. Sold it all,” saying he exited AMD shares bought “last June” along with his Direxion Daily Semiconductor Bull 3X Shares (NYSEARCA:SOXL) trade. He offered to verify the gain with video or brokerage statements. No proof has been posted, so the $16 million figure is still unconfirmed. He explained why he sold:
“I think the market has genuinely cracked under the macro pressure. Not going to open any equity longs for a while.”
Testing the Exit Call Against the Data
AMD rose 361.27% from $114.63 in early June 2025 to $528.75 at Friday’s close. It is up 158% year to date. The stock then fell 9.96% in a week. Jim Cramer described how fast the run happened on Mad Money:
“That’s how AMD could go from $188 in March to $658 by last week. Now we’re finding that maybe these moves were too big, too fast.”
The broader market stayed calm. The VIX peaked at 16.87 on October 14 and closed at 16.46 the next day, which is within its normal range. The day before the post, Taiwan Semiconductor Manufacturing guided fourth-quarter revenue up 58% year over year.
AMD’s Revenue and Earnings Kept Growing
AMD’s second-quarter revenue rose 50.1% to $11.54 billion, ahead of the $11.31 billion consensus. Non-GAAP EPS came in at $1.66, above the $1.61 estimate. Data Center revenue grew 107% to $6.72 billion. CEO Lisa Su said on the call:
“We are still in the early stages of a multi-year AI adoption cycle as deployments grow across a broad set of markets and workloads.”
“We now expect revenue to grow substantially above our prior target of greater than 35%, and we expect to significantly exceed our $20 annual EPS target within our strategic timeframe.”
Third-quarter guidance is about $13 billion. Meta Platforms (NASDAQ:META) plans to deploy up to 6 GW of Instinct GPUs, and Anthropic targets up to 2 GW.
How AMD Stacks Up Against NVIDIA and Intel
Competitor NVIDIA (NASDAQ:NVDA) is up only 17.27% this year and slipped 4.84% last week. Intel (NASDAQ:INTC) gained 156% year to date, then fell 10.59% last week. The selling hit this year’s biggest gainers hardest. On fundamentals, AMD reported its fifth consecutive quarter of record server CPU revenue and took x86 server share from Intel.
Reasons a Seller Might Want Cash
AMD trades at about 199 times earnings. Gaming revenue fell 31%, and supply is constrained. Su said:
“The server CPU supply chain is tight right now, and it has been tight for the first half of the year because much of this demand was unforecasted.”
Reddit sentiment on AMD plummeted from bullish to very bearish. Big institutions disagree. In 13F filings for the second quarter, 11 of 22 tracked funds added shares, while 8 cut.
Did He Sell Too Soon? What to Watch Next
The data shows a stock pulling back after a sharp run while the broader market stayed calm. Helios shipments were scheduled to begin in Q3 2026, so AMD’s third-quarter report will test whether demand is holding up. Riding a mania is one skill; knowing when to walk away is another, and we covered both sides in a free bubble survivor’s handbook. The Reddit member closed with this advice:
“Be grateful for whatever the market gives you, whether that be money or a lesson in mental discipline.”
Got $1,000? Before You Buy AMD, Read ThisIf you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And AMD wasn't one of them.
They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>
Contact [email protected] for any questions or corrections.
Advanced Micro Devices (AMD +2.72%) stock jumped 3.6% through 12:30 p.m. ET Monday.
You can thank the friendly analysts at TD Cowen for that. AMD stock may have lost 16% of its value over the past two weeks as semiconductor stocks sold off, but Cowen still thinks AMD stock is a buy.
Image source: The Motley Fool.
Why Cowen loves AMD stockTD Cowen analyst Joshua Buchalter reiterated his buy rating and $675 price target on AMD this morning, citing "growing adoption of agentic AI and production inference workloads." Whereas AI training requires GPUs, you see, AMD's CPUs are better suited for "coordination of multi-step workflows, tool calls, API management, and sequential decision-making" in agentic AI.
AMD seems to agree. The company recently doubled the estimated size of its total addressable market to $220 billion and predicted its sales of CPUs for AI data centers will rise 70% in 2027.
AMD Advanced Micro Devices$543.15+$14.40 (+2.72%)
NASDAQ · As of 1:19 PM ET 10/19/26
What's next for AMD stockIs that enough to make AMD stock a buy?
At first glance, the stock still looks richly priced at more than 156 times trailing earnings. But here's the thing: That P/E ratio is based on AMD's $6.4 billion in reported net income. When valued on free cash flow, though, AMD is actually generating more than $8.4 billion in real cash profit.
And that's enough to drop the company's price-to-free cash flow ratio down to just 102x.
Mind you, a P/FCF ratio of 102x still is not obviously "cheap," but with a long-term forecast growth rate of 60%, the stock's price-to-FCF-to-growth ratio is only about 1.7 -- a lot cheap-er than its PEG ratio of 2.6.
While not an obvious bargain, AMD stock is at least a bit cheaper than it looks. While I hesitate to buy it myself, I see why Cowen might think it's a buy.
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices. The Motley Fool has a disclosure policy.
Nvidia představila otevřený model Nemotron 3.5 Super VL se 120 miliardami parametrů pro podnikové AI agenty a dva modely Bolt určené pro lokální běh na AI PC a pracovních stanicích.
Nvidia on Thursday launched new open-weight models designed for always-on agents and edge computing.
The Nemotron 3.5 Super VL is a large, 120-billion-parameter model geared for agents used by the enterprise. While it uses fewer parameters than the Nemotron 3 Ultra model, Nvidia says it can deliver similar accuracy in instruction-following and tool-use tasks.
At the other end of the spectrum, the company also launched two lightweight Bolt models. These are intended to run locally on the new AI PCs (running the Nvidia RTX Spark chip) and workstations running the DGX Spark. Such PCs, aimed at consumers, programmers, and enterprise knowledge workers, are being released right now into the market through partners like Microsoft and Dell.
“Any organization that wants to run agents on Nvidia infrastructure now has an open, optimized model for their tier without having to choose between capability and deployability,” Nvidia’s vice president of Open Models and Software, Kari Briski, wrote in the blog post announcing these models.
Nvidia claims that the Super VL completes tasks faster than competing models from Anthropic and OpenAI (Opus 5, GPT 6.1 Sol, Luna, Astra) when post-trained on specific agentic tasks. These tasks include document intelligence, financial accounting, scientific experimentation, medical insurance claims, and security attack resilience.
While such claims are standard whenever a major tech company announces a new model, Nvidia has backed it up with a list of heavy-hitter companies that it says are using Super VL. These include Skydance, EY, Ramp, Crowdstrike, Perplexity, and Salesforce.
Of course, these aren’t the first open-weight models that Nvidia has released that compete with the proprietary frontier labs — companies that are both its customers and its investments. The GPU giant has an entire family of Nemotron models that do everything from multimodal artificial intelligence to reasoning, coding, math, and enterprise automation.
However, those fast-growing proprietary AI labs are now looking to many other chips and AI system makers beyond Nvidia to power their needs, like AWS’s Trainium and Cerebras, as well as building their own home-grown chips.
So Nvidia is leaning hard into the trend of enterprise companies wanting to run their own open models in their own data centers. “Unlike closed frontier models, organizations can post-train Super VL on their own data, deploy it on their own infrastructure and own what they build,” Briski wrote.
But with the announcement or the smaller, local PC models, it is also trying to push forward the nascent trend of consumer AI assistants. While it seems a new AI assistant is introduced every day by startups and Big Tech alike, privacy-weary consumers may not want to invite such agents so deeply into their lives giving them access to info about their families, health, finances, and so on.
So, while Nvidia hopes to create a new market for itself selling PCs powered by its chips by creating machines that run the models and agents locally, PC users “can delegate everyday projects … without sending those workloads to the cloud,” Briski wrote.
Of the two Bolt models, Nemotron 3.5 Bolt 74B-A9B 24GB is a 74-billion parameter model designed for local agentic tasks. It is intended to balance speed with reasoning to handle multistep reasoning, tool calling, and web browsing. The smallest Bolt E4B is aimed at conversational agents.
Super VL and Bolt 74B-A9B are available now, with Bolt E4B coming later this month, Nvidia says.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Jensen Huang says compute is now revenue, and NVIDIA's latest numbers back him up. But whether Wall Street's already-aggressive targets actually undershoot where this stock is headed depends on a few catalysts that could change the math entirely.
NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) chief executive Jensen Huang sums up the moment in one line: “AI has reached its inflection point. It’s doing useful work. Its tokens are productive and profitable. Now, compute is revenue.”
The latest quarter at NVIDIA supports him. Second-quarter fiscal 2027 revenue reached $96.22 billion, up 105.8% year over year, and Data Center sales rose 117% to $89.02 billion.
Shares are up 20.15% year to date at $223.55 and have gained 932.51% over five years. Earnings are growing faster than the stock price, though, which leaves room for a revaluation. Here’s how NVIDIA could hit $400 in 2027.
Wall Street Already Sees 47% Upside The average analyst price target is $328.72, which means about 47% upside. Coverage has 10 Strong Buy and 49 Buy ratings against just one Sell.
Estimates keep rising. Consensus EPS for fiscal 2028 stands at $15.9146, compared with $12.7102 90 days ago. Over the past 30 days, analysts made 46 upward revisions and zero downward.
That works out to about 71% growth from the $9.3124 expected this fiscal year. NVIDIA has also exceeded EPS estimates for 6 consecutive quarters, most recently posting $2.22 against $2.0887 expected. A run like that suggests actual results could come in above forecasts.
Here’s the Math Behind $400 Per Share At today’s price, NVIDIA trades at 14x fiscal 2028 estimates. The S&P 500 trades at roughly 21-23x forward earnings, so NVIDIA is cheaper than the average stock despite growing much faster.
At $400, shares would trade at about 25x forward earnings. That is a modest premium for a business expected to grow EPS by roughly 71%.
What Could Push NVIDIA to $400? Vera Rubin: Purchase orders have arrived from “every major hyperscaler, AI cloud, and system OEM,” and management expects it to be “the fastest product ramp in NVIDIA’s history.” Each gigawatt of Vera Rubin represents a $40 billion revenue opportunity, compared with $25 billion for Blackwell. Demand above supply: Management guides to roughly 70% revenue growth in fiscal 2028 and says “customers’ forecasts point to our growth doubling next year.” Hyperscaler spending: Capital spending by the top five hyperscalers is expected to rise from nearly $800 billion in 2026 to $1.3 trillion in 2027. Key deals: AWS is deploying an additional 2 million GPUs, and OpenAI’s commitments total about 12 gigawatts of NVIDIA computing power. Buybacks: NVIDIA returned $26 billion to shareholders last quarter and has about $99 billion left under its buyback authorization. There are hurdles. Memory costs could push gross margin down to a 71% to 72% low, the outlook includes no China data center revenue, and supply stays tight through fiscal 2028.
NVIDIA Has Topped 79% in 10 Years Since 2000 Hitting $400 requires a gain of about 79%. Since 2000, NVIDIA has gained more than that in 10 calendar years.
Shares rose 239% in 2023, 171% in 2024, 227% in 2016 and 125% in 2021. At a market cap of about $5.395 trillion, repeating those gains is harder, but the record shows the stock can move this much.
$400 Is a Stretch, but Here’s Why It’s Possible A move to $400 would take a 79% gain in 2027. Analysts already expect 47% upside, estimates are rising quickly, and the stock trades below the market multiple.
If Vera Rubin ramps as planned, hyperscaler spending holds up and the beat run continues, a 25x multiple is a reasonable outcome. Such returns are rare, yet this is how NVIDIA could deliver outsized returns in 2027.
Contact [email protected] for any questions or corrections.
Netflix propustí zhruba 6 % zaměstnanců, přesto vedení očekává, že splní celoroční výhled tržeb ve výši přibližně 51 miliard USD, což představuje meziroční růst o 13–14 %.
Netflix (NFLX -1.43%) reports earnings on Tuesday, and the company's Co-CEO Ted Sarandos didn't give investors reason to be bullish about the numbers. The company is laying off approximately 6% of its workforce, and Sarandos has recently said that the business simply is "not growing as fast as I want."
These are not things that investors want to see heading into the streaming company's earnings release, as they could suggest a weak quarter is on deck. And that's bad news for a stock that's already been nosediving for much of the year.
Image source: Getty Images.
The company is still on track to hit its forecastDespite the struggles Netflix is facing right now, according to a memo that CNBC has seen, management told its employees that it's still "on track to deliver our full year forecast."
When the company last released earnings in July, it reported 13% revenue growth. It also forecasted that for the full year, its revenue will rise by around 13% to 14%, totaling approximately $51 billion. It's a decent growth rate, but one that clearly management isn't thrilled with. It also comes as Netflix has raised prices this year across all of its plans; investors may have been expecting better growth.
Netflix has been investing more in content and sporting events, and thus, there may be more of a need to show a payoff from such investments.
NFLX Netflix$69.53-$1.01 (-1.43%)
NASDAQ · As of 1:12 PM ET 10/19/26
Netflix's stock is cheap, but is it in danger of going lower?It's been an exceptionally bad year for Netflix, as its shares have fallen more than 25% thus far, while the S&P 500 has risen by around 13%. That's not typically what investors would expect to see from a growing business, and it signifies the worry that the market has about Netflix's future growth; a premium may be hard to justify given the uncertainty ahead.
Currently, the stock is trading at a forward price-to-earnings multiple of under 19, which is in line with the average stock on the S&P 500. Arguably, however, the stock deserves a better multiple given its growth prospects, as sports, gaming, and international expansion could still open up more potential for the business in the long run.
Its growth rate remains solidly in double digits, which is an encouraging sign that even with multiple rate hikes over the years, consumers continue to see compelling value in its streaming plans. The business may need some tweaks, but I don't think it's in as dire a situation as its sell-off this year might suggest; at a reduced valuation, now could be a great time to buy the stock, as I don’t think it’s likely to go a whole lot lower.
You're currently following this author!
Click to unsubscribe from email alerts.
Author of the CMO Insider: Creator Brief newsletter
Dan Lin, with Ava DuVernay, is Netflix's latest exec cut.
Kate Green/Getty Images for Netflix
Film head Dan Lin is out at Netflix, the latest exec to be ousted in the wake of the streamer's biggest layoff since 2022.
Lin was hired as film chair in 2024 with a mandate to bring greater cost discipline and variety to Netflix's films, which had focused on big-budget output under his predecessor, Scott Stuber. Lin cut big upfront paychecks to actors, reduced staff, and reorganized his department. He oversaw a slate that included Oscar-winning "KPop Demon Hunters," "Happy Gilmore 2," and "Frankenstein."
Lin's exit is the latest big shocker at Netflix. Also out in recent days was chief content officer Bela Bajaria, who was replaced by Hollywood veteran Peter Rice, a former exec at Disney and Fox.
Rice will oversee film until a new head is announced, Netflix said in a statement confirming Lin's departure.
Last week, Netflix laid off 1,000 employees, or about 6% of global head count. That was the streamer's largest cull since 2022, when the company lost subscribers for the first time in more than a decade.
The streaming giant has been hampered by slowing engagement growth and a stock price that has declined more than 40% over the past year. The streamer is contending with the rise of free, ad-supported streaming led by YouTube and the popularity of social video. In recent months, Netflix has turned to podcasters and creators to bulk up its library.
Netflix is set to report third-quarter earnings after the bell on Tuesday.
Read next
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Lucia Moses
You're currently following this author!
Click to unsubscribe from email alerts.
Lucia Moses covers the media and entertainment business, with a focus on how creators build businesses, how media companies intersect with creators, and how marketers adopt entertainment tools. She's broken stories about MrBeast's ambitions, Google's movie initiative, and Netflix's push into podcasts.She previously reported on media and managed teams at Digiday and Adweek.
Visa integruje Unified Checkout do platební brány Smartpay Fuse společnosti Barclaycard Payments, což britským obchodníkům umožní prostřednictvím jediného napojení přijímat platební karty, digitální peněženky i Click to Pay.
Key Takeaways Visa integrates Unified Checkout into Barclaycard's Smartpay Fuse gateway to simplify online payments.One integration supports cards, Click to Pay, digital wallets, Pay by Link and invoicing for U.K. merchants.V's partnership could drive wider adoption of value-added services and strengthen UK merchant relationships.
Visa Inc. (V - Free Report) is expanding its merchant payment capabilities in the United Kingdom through an enhanced partnership with Barclaycard Payments. The companies announced the deployment of V’s Unified Checkout solution, which is designed to simplify online payment acceptance and help merchants improve e-commerce conversion. The agreement builds on their six-decade relationship in payments and acceptance.
Under the arrangement, Barclaycard Payments is integrating Unified Checkout into its Smartpay Fuse payment gateway. A single integration will allow merchants to accept card payments, Click to Pay and digital wallets, while also supporting Pay by Link and invoicing. Its modular, API-driven architecture allows businesses to adapt payment capabilities as customer preferences evolve, while the low-code design reduces development requirements and simplifies the addition of new services.
The move strengthens V’s value-added services portfolio by addressing a practical challenge for merchants: offering convenient payment choices without adding unnecessary technical complexity. A smoother checkout can help reduce abandoned transactions, while flexible payment options may improve customer satisfaction. For Barclaycard Payments, the integration also enhances its gateway offering, potentially making it more attractive to businesses seeking simpler payment management.
The agreement supports V’s broader strategy of expanding its role beyond transaction processing into services that deepen merchant and financial institution relationships. Embedding its technology within an established payment gateway expands Visa’s distribution opportunities and could encourage wider adoption of its value-added services among U.K. merchants.
The partnership could strengthen V’s competitive position as payment providers seek to differentiate themselves through integrated technology, security and merchant services rather than payment processing alone. If executed well, it could support additional services revenue opportunities and reinforce Visa’s merchant relationships.
How Are Competitors Faring?Some of V’s competitors in the payments space include Mastercard Incorporated (MA - Free Report) and American Express Company (AXP - Free Report) .
Mastercard is advancing digital checkout through wider adoption of Click to Pay, tokenization and biometric payment passkeys. MA’s push toward eliminating manual card entry across Europe by 2030 could improve transaction security, merchant conversion and payment efficiency.
American Express is strengthening merchant acceptance through payment gateway solutions, Click to Pay and fraud prevention tools. AXP’s network now covers more than 190 million merchant locations globally, supporting wider payment access and deeper relationships with businesses and cardholders.
PepsiCo (PEP +0.87%) has been having a difficult year, with sluggish sales of soft drinks and snack foods as well as decreasing margins. And now, it just got some more bad news.
On Oct. 15, fried chicken chain KFC announced it will switch from serving Pepsi products to serving Coke products in its 4,000 U.S. locations. That's a big win for Coca-Cola (KO -0.36%). Though the loss in overall sales from the switch is fairly modest relative to PepsiCo's overall beverage sales, it's more significant symbolically.
In terms of revenue, the KFC-Coca-Cola deal is expected to cost PepsiCo some $50 million. The company's North American Beverages unit had sales of $7.7 billion in the third quarter.
Image source: Getty Images.
Keep in mind, however, that PepsiCo once owned KFC, as well as Pizza Hut and Taco Bell, but spun the three off in 1997 to create a company that later became Yum! Brands. So the company had a long and special relationship with the chicken chain known for its founder and brand ambassador, Colonel Sanders. The KFC decision ends a 40-year friendship that began when PepsiCo acquired the chain back in 1986.
It's the third big loss for PepsiCo to Coke this year It's not PepsiCo's first loss to Coca-Cola this year. In July, Marriott International announced a deal with Coca-Cola to switch from Pepsi products, and Costco Wholesale recently did the same.
Interestingly -- and perhaps tellingly -- KFC made the switch in an attempt to help its own flagging fortunes. The chain is trying to win back customers it lost in recent years to rivals Popeyes and Chick-fil-A, and it believes switching to Coke products will help that effort.
PepsiCo reported third-quarter earnings earlier this month, and they were slightly better than expected. Revenue of $25.3 billion was 5.6% higher than a year ago, and earnings per share were $2.34, compared to $2.29 a year ago. Both were slightly higher than Wall Street forecasts. Management, however, lowered its full-year 2026 guidance for both organic revenue and earnings growth.
PEP PepsiCo$132.63+$1.14 (+0.87%)
NASDAQ · As of 1:12 PM ET 10/19/26
PepsiCo's major snack brands are also highly exposed to people cutting back on processed snacks due to changing consumer habits and the rapid adoption of appetite-suppressing GLP-1 drugs. Lay's, a major brand of the company, is considered one of the products most exposed to the shift in calorie intake due to GLP-1s.
Coca-Cola has held up better against these trends. While studies show that people using GLP-1 drugs consume less full-sugar soda, some 68% of the company's portfolio consists of low- or no-calorie options. Perhaps that's why PepsiCo's stock is down 8.7% this year, while Coca-Cola shares have climbed 34%.
It seems PepsiCo still has a lot of work to do to turn things around.
Pfizer zachovává čtvrtletní dividendu na úrovni 0,43 USD, přestože dividendy v roce 2025 představovaly 108 % volného peněžního toku. Generální ředitel se zavázal dividendu zachovat.
Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash generation. The math behind that payout is more uncomfortable than the headline numbers suggest.
Pfizer (NYSE:PFE | PFE Price Prediction) declared its quarterly dividend again on Oct. 6, 2026, at $0.43 per share. That’s the same amount it has paid since early 2025. The board held the payout steady after years of annual raises. The last increase took it from $0.42, a bump of about 2.4%. With shares at $29.58, up 24.96% year to date, the stock still yields roughly 5.80%. That raises the question: can Pfizer keep paying it?
Earnings Cover the Dividend, but Cash Flow Is Thin Pfizer’s 2026 adjusted EPS guidance is $2.80 to $3.00. Against that guidance, the $1.72 annual dividend works out to a payout ratio of about 57% to 61%. Cash flow looks less comfortable. In 2025, operating cash flow minus capital spending came to about $9.08 billion, while dividends cost $9.77 billion. That means the payout ate up about 108% of free cash flow. In the first half of 2026, free cash flow was roughly $2.48 billion, while the company paid $4.9 billion to shareholders. GAAP profits keep taking hits from write-downs, including a $3.8 billion impairment on Sigvotatug vedotin in the second quarter.
Debt From Pfizer’s Dealmaking Limits Its Options Total debt rose from $35.8 billion at the end of 2022 to $63.2 billion by June 30, 2026, while cash sat at just $976 million. Management put leverage at 2.7 times and offered no promise that it would fall soon:
“Given the LOE impact over the next few years, we expect leverage to remain around current level or modestly higher through this transition period.”
Buybacks are on hold. Pfizer’s 2026 guidance assumes no share repurchases, and $3.3 billion of authorization remains unused.
Pfizer’s Plan to Replace Revenue Lost to Patent Expirations Generic and biosimilar competition will cost Pfizer about $1.1 billion in revenue this year, and the larger loss-of-exclusivity (LOE) wave, when key patents expire, is still to come. To offset it, launched and acquired products grew 18% operationally in the second quarter. A patent settlement extends U.S. exclusivity for Vyndamax, a heart-disease drug, to June 2031. Cost programs aim for about $9.7 billion in net savings through 2029. Chief executive Albert Bourla addressed the payout directly on the second-quarter call:
“We feel extremely confident that, even in the most stretched scenarios that we are running, we will be able to maintain our dividend. So I want, once and for all, to make that clear to all: the dividend will be maintained, and eventually, after the LOE period, we will start growing it again.”
He also pointed to a “risk-adjusted, high single-digit revenue CAGR from year-end 2028 through year-end 2033,” with obesity drugs from the Metsera deal aiming for a first approval in 2028.
How Bristol Myers and Merck Compare Despite its own generic erosion, Bristol-Myers Squibb (NYSE:BMY) still raised its dividend to $0.63 per quarter. That was a 1.6% increase and its 17th consecutive annual raise. Bristol also lifted its 2026 EPS outlook to $6.75 to $7.00. Chief executive Christopher Boerner said, “The Growth Portfolio continues to deliver.”
Merck (NYSE:MRK) is paying the cost of rebuilding its pipeline. One-time charges of $9.0 billion for Cidara and $5.7 billion for Terns pulled its 2026 non-GAAP EPS outlook down to $2.66 to $2.76. Merck can absorb charges of that size from a $360 billion market cap. Pfizer is worth about $168.6 billion.
Verdict: Safe for Now, With No Growth Until the End of the Decade Adjusted earnings cover the dividend well, and management has staked its credibility on keeping it. Free cash flow, though, has fallen short of the payout, and the debt load leaves little room for error. The current $0.43 looks safe through the patent-expiration years. Pfizer’s own plan also makes clear that raises are unlikely to resume before the 2029 return to growth. Until then, keep an eye on free cash flow coverage and leverage.
Contact [email protected] for any questions or corrections.
Pfizer ve třetím čtvrtletí očekává pokles tržeb z vakcíny Comirnaty a přípravku Paxlovid kvůli slabší poptávce po léčbě COVID-19, zatímco tržby z Eliquisu by měly růst díky globální poptávce.
Key Takeaways Pfizer's non-oncology results will highlight performance across Primary Care and Specialty Care in Q3.Eliquis demand may boost sales, while lower COVID-19 demand will weigh on revenues.Vyndaqel sales may rise on international strength, while Xeljanz and Enbrel sales likely continue to decline. Pfizer (PFE - Free Report) will announce its third-quarter 2026 earnings on Nov. 3, and investors will be watching the performance of its oncology business closely, as the segment generates nearly 27% of the company's total revenues. Its key cancer medicines include Ibrance, Xtandi, Lorbrena, Braftovi/Mektovi and Padcev.
Apart from oncology, Pfizer has a broad portfolio spanning primary care, vaccines, inflammation and immunology, rare diseases and other specialty therapies. These businesses are organized under the company's Primary Care and Specialty Care segments.
Here’s a closer look at the expected third-quarter performance of Pfizer’s therapies across these two non-oncology business segments.
In Primary Care, alliance revenues and direct sales from Bristol-Myers (BMY - Free Report) for the blood thinner Eliquis are likely to have risen, driven by higher demand trends globally, partially offset by price and generic erosion in some ex-U.S. markets. As regards sales of key vaccine Prevnar, higher sales in ex-U.S. markets are likely to have been offset by the impact of lower demand in the United States.
Pfizer records direct sales and alliance revenues from its partner, BioNTech (BNTX - Free Report) , for the COVID-19 vaccine, Comirnaty. Revenues from Pfizer/BioNTech’s Comirnaty are likely to have declined in the third quarter due to lower U.S. utilization following narrower vaccination recommendations. Sales of the antiviral pill for COVID, Paxlovid, should also have declined due to lower infection rates, which hurt demand trends and lower international government purchases.
Sales of respiratory syncytial virus (RSV) vaccine, Abrysvo, are likely to have gained from launch uptake in some international markets, although vaccination recommendations and competition may constrain growth in United States. Favorable timing of deliveries in some international markets and favorable buying patterns in the United States benefitted sales in the second quarter, which may have reversed in the third quarter. Sales of migraine drug, Nurtec ODT/Vydura, are likely to have benefited from strong demand and prescription growth in the United States.
In the Specialty Care unit, sales of Vyndaqel are expected to have risen, as higher sales in international markets may offset lower revenues in the United States due to the impact of price erosion as a result of new payer contracts in the United States.
Sales of Xeljanz and Enbrel may have declined due to competitive and pricing pressures. In contrast, newer medicines such as Cibinqo could benefit from continued market uptake.
Pfizer’s Key Competitors
In inflammation & immunology, Pfizer’s key competitors include AbbVie, Johnson & Johnson, Amgen and Novartis. In areas such as diabetes, cardiovascular disease, obesity, and other chronic conditions, Pfizer faces competition from Eli Lilly, Novo Nordisk, Merck (MRK - Free Report) , AstraZeneca and Sanofi. In vaccines, it competes primarily with Merck, GSK, Sanofi and Moderna.
Cisco's AI order book has management calling it a networking supercycle, and shareholders want to know if a $200 share price is the payoff. A fresh model breaks down exactly how far the rally can realistically run and what stands…
Cisco Systems (NASDAQ:CSCO | CSCO Price Prediction) has run hard on AI networking demand, and the obvious next question for shareholders is whether $200 a share is on the horizon. We modeled what a $1,000 investment could become by 2031, starting from a reference price of $113.64.
Shares were changing hands near $109.13 noon, down 3.97% on the session. With an AI order book that management calls a supercycle, Cisco deserves a fresh forward look.
Your $1,000 Could Reach About $1,563.50 by 2031 In the five-year base case, a $1,000 investment might reach roughly $1,563.50 by 2031, a total return of 56.35%. The estimate assumes a modeled share price of $177.67 on October 15, 2031, which works out to 9.35% a year.
Neither horizon in the model gets Cisco to $200. The highest target is the five-year bull case at $187.86. Getting to $200 from the reference price would take a gain of 75.9944%. That makes $200 an hypothetical stretch scenario beyond 2031. The model gives no date for it.
Bull, Base and Bear Scenarios for a $1,000 Stake Scenario Horizon Target Price Total Return Value of $1,000 Bull 2031 $187.86 65.31% $1,653.10 Base 2031 $177.67 56.35% $1,563.50 Bear 2031 $120.89 6.38% $1,063.80 Bull 2027 $138.12 21.54% $1,215.40 Base 2027 $130.14 14.52% $1,145.20 Bear 2027 $109.27 -3.84% $961.60 The model gives its forecast a confidence score of 0.9, which it rates as high. Wall Street’s consensus target is $136.16. The analyst count is 5 strong buys, 14 buys, 10 holds and 0 sells.
Three Drivers Behind Cisco’s Upside Case AI Orders Are Turning Into Revenue Cisco took in $9.30B of AI orders in fiscal 2026 and guided AI infrastructure revenue to about $7.5B in fiscal 2027, up from roughly $4 billion. Chief Executive Chuck Robbins called it “a multi-year, multi-billion dollar networking super cycle.” In the fourth quarter, networking product orders grew 40% year over year.
Guidance Points to Faster Earnings Growth Management expects fiscal 2027 revenue of $72.2B to $73.4B and non-GAAP EPS of $5.05 to $5.11, compared with $4.33 in fiscal 2026. The model works from forward EPS of $5.146 and a forward P/E of 22. A higher multiple on those earnings is how the long-term path gets built.
Consistent Beats and Steady Capital Returns Cisco has exceeded EPS estimates for 6 consecutive quarters. Its latest report showed $1.22 against a $1.17 estimate, on revenue of $17.25B. Shareholders collect a $0.42 quarterly dividend, and $8.1B remains on the buyback authorization.
Risks That Could Sink the Projection Margins are already under pressure. Non-GAAP gross margin fell to 66.3% from 68.4% as AI hardware took a larger share of the mix, and the CFO expects a slight drag in fiscal 2027. The AI growth story leans on hyperscaler capital spending, which can change fast (we covered seven of the suppliers riding that expansion, from power to networking, in a free report here).
Fiscal 2027 guidance already includes tariffs and a restructuring plan announced on May 13, 2026, and execution on both could fell. Geopolitics and supply constraints add further uncertainty.
The stock is also volatile. Shares are up 61.84% over the past year but down 7.04% over the past week, and the 52-week high is $129.38.
Retail view is also marked as bearish. The next test comes with the fiscal first-quarter earnings report on November 12, 2026, where guidance calls for revenue of $18.0B to $18.2B.
What Your $1,000 Could Become By 2031, the model puts a $1,000 Cisco investment somewhere between $1,063.80 and $1,653.10, with $1,563.50 as the base case. A $200 share price stands above even the bull case, so it remains outside the modeled outcomes. The modeled scenarios above do not constitute investment advice.
Contact [email protected] for any questions or corrections.
Palantir just struck a federal cloud deal that sent its stock surging past every defense peer and market benchmark, but with shares trading at a 263x earnings multiple, the real question is whether this partnership signals a breakout or sets…
A new federal cloud alliance is putting Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) well ahead of the government contractors it competes with for agency software work. Palantir stock is up 5% to $195.36 in early trade, a rebound fueled by a new partnership with Knox Systems.
Meanwhile, Leidos (NYSE:LDOS) stock is up 1% to $126.38, a gain that trails the advance in Palantir shares by a wide margin. Booz Allen Hamilton (NYSE:BAH) shares are down 1% to $73.41, moving in the opposite direction from Palantir stock.
Two funds help show how specific the rally in Palantir shares is. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 0.8%, so the broad market is stronger as well. However, the iShares U.S. Aerospace & Defense ETF (CBOE:ITA) is down 0.3%, leaving Palantir stock ahead of both funds and of Leidos and Booz Allen Hamilton shares, a gap that ties the move to the Knox partnership.
Knox Partnership Opens a Faster Federal Cloud Path Palantir and privately held Knox Systems announced the deal, aiming it at customers working in Federal Risk and Authorization Management Program (FedRAMP) and high-security Department of War cloud environments. Knox runs a large managed federal cloud and offers an accelerated path to FedRAMP authorization. On the other side of the deal, Palantir has helped software companies deploy to the federal government on its own accredited infrastructure.
Kevin Kawasaki, Palantir’s global head of business development, stated, “The mission can’t wait for technology to catch up.” Combining Knox’s authorization path with Palantir’s accredited infrastructure is designed to shorten the road for commercial software makers trying to reach defense customers.
Federal Revenue Momentum Gives the Deal Weight In Q2 2026, Palantir’s U.S. Government revenue rose 90% year over year to $809 million, while total revenue grew 92.8% to $1.94 billion. Chief Executive Alex Karp tied that growth to sovereign AI, declaring in the Q2 earnings release, “Demand for AI sovereignty has now been unleashed.”
Gotham for federal work, Foundry for business clients and the Artificial Intelligence Platform (AIP) ground the data and AI software Palantir sells to government and commercial customers. Leidos and Booz Allen Hamilton run a different model, earning most of their revenue from government services and IT contracts.
Palantir’s U.S. Commercial revenue grew 149% year over year to $764 million in Q2. Palantir’s total contract value reached $3.37 billion.
AI Valuation Debate Hangs Over the Rebound The advance in Palantir shares comes after the stock fell sharply in the prior session during a broad technology selloff. Shares of Palantir trade at a P/E ratio of 263x, a premium multiple that magnifies reactions to federal contract news (we also pulled together seven companies driving the AI expansion beyond the chipmakers in a free report here).
Risk factors in Palantir’s Q2 materials include long and unpredictable sales cycles and customer contracts subject to termination-for-convenience provisions. Its reliance on stock-based compensation, which reached $265 million in Q2, adds another point of contention for Palantir shareholders. The company also flags revenue concentration in the U.S. market, which ties its fortunes closely to domestic federal and commercial spending.
Knox Adoption Becomes Palantir’s Next Proof Point Now investors can watch for whether Knox brings more software makers onto Palantir’s federal infrastructure. Federal growth backs bulls and the premium valuation backs bears, so caution fits: investors may keep their positions modestly sized.
Palantir’s management expects Q3 2026 revenue of $2.16 billion to $2.164 billion. Palantir’s next quarterly report could show whether federal momentum holds after the Knox announcement.
Contact [email protected] for any questions or corrections.
Micron má objem nasmlouvaných zakázek ve výši 150 mld. USD a více než 35 % tržeb zajištěných až do roku 2030. Poptávka po HBM má ve fiskálním roce 2027 zvýšit marže.
SummaryMicron Technology, Inc. is re-rated as a Buy, supported by strong revenue visibility, pricing power, and robust demand through FY30.CXMT’s technological advancements pose a long-term threat, but meaningful competitive impact on MU is unlikely before 2028.MU’s HBM segment is narrowing its margin gap with conventional DRAM, with higher selling prices and strong demand driving margin expansion in FY27.With a $150B backlog and 35%+ revenue covered through 2030, MU’s risk-reward profile remains attractive despite competitive and supply risks. amgun/iStock via Getty Images
Investment Thesis Investors are punishing AI-related stocks due to many of them needing to take on high debt to expand their operations and build new data centers.
Since my last coverage, Micron Technology, Inc. (
1.81K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
BlackBerry spustila QNX Launchpad, který firmám s ročními tržbami do 10 milionů USD nabízí levnější software QNX pro komerční robotiku, automatizaci a zdravotnická zařízení.
Key Takeaways BB introduces QNX Launchpad to help startups develop commercial products for mission-critical applications.Eligible businesses with up to $10M in annual revenue gain access to QNX software at startup-friendly costs.The initiative supports BlackBerry's expansion into robotics and medical devices beyond automotive. BlackBerry Limited (BB - Free Report) has introduced QNX Launchpad, a new initiative aimed at helping startups and small and medium-sized businesses (SMBs) develop commercial products for mission-critical applications. The program provides eligible companies with access to production-ready QNX software at startup-friendly costs, allowing them to allocate more resources toward product development, talent acquisition and business expansion.
The initiative comes as physical AI and software-defined systems gain traction across industries. Technologies such as autonomous mobile robots, robotic arms and surgical robots are increasingly moving beyond research environments into commercial applications. For emerging businesses developing these products, selecting a reliable software foundation early can be crucial to ensuring safety, scalability, performance and faster time to market.
QNX Launchpad addresses the financial challenges associated with adopting commercial-grade software during the initial stages of product development. Through the program, qualifying businesses can access the QNX Software Development Platform (SDP) 8.0, enabling them to build products on a dependable software architecture without making substantial upfront investments.
The program includes access to QNX development seats, QNX OS, QNX OS for Safety, QNX Hypervisor, QNX Hypervisor for Safety, QNX Sound and other commercial software offerings. Participants can also benefit from technical assistance, embedded engineering expertise and a broader ecosystem of compatible hardware, software and development tools.
Eligibility extends to startups and SMBs generating annual revenues of up to $10 million and developing products for commercial sale. Businesses associated with recognized incubators or accelerator programs may qualify for additional benefits.
QNX Launchpad complements the existing QNX Everywhere initiative, which offers free software access for non-commercial learning, evaluation and prototyping. Together, these programs aim to encourage early adoption of QNX technology and support companies as they transition toward commercial deployment.
The launch also aligns with BlackBerry's strategy to expand QNX beyond automotive into general embedded markets, including robotics, industrial automation and medical devices. In second-quarter fiscal 2027, management highlighted these markets as important long-term growth opportunities.
BlackBerry operates in competitive and rapidly evolving markets where product capabilities, pricing, reliability and compatibility influence customer decisions. QNX faces ongoing requirements to invest in software development, safety certification and ecosystem integration as automotive and embedded systems become more complex.
Taking a Look at BB’s CompetitorsBlackBerry faces stiff competition from NVIDIA Corporation (NVDA - Free Report) , Qualcomm Incorporated (QCOM - Free Report) , CrowdStrike Holdings (CRWD - Free Report) and others.
NVIDIA continues to benefit from broad demand for accelerated computing as customers build AI factories across hyperscalers, AI clouds, enterprises and sovereign buyers. NVIDIA recently announced the expansion of its open-source CUDA-Q platform with CUDA-Q Logical, an orchestration layer designed to accelerate the development and testing of fault-tolerant quantum computing applications.
Quantum is benefiting from rising demand for cost-efficient data storage, supported by adoption of ActiveScale object storage and Scalar tape systems. For the second quarter of fiscal 2027, Quantum expects revenues of $82 million, plus or minus $2 million.
CrowdStrike benefits from durable cybersecurity demand, broader Falcon adoption, expanding AI security capabilities and rising use of Falcon Flex. CrowdStrike recurring subscription model, healthy liquidity and free cash flow generation also support continued investment and customer expansion.
Eli Lilly ve druhém čtvrtletí zvýšila tržby o 47,67 % na 22,97 miliardy USD a dosáhla zisku na akcii (EPS) 8,38 USD; výhled tržeb na rok 2026 zvedla na 85–87 miliard USD.
Eli Lilly just crushed earnings again and sits within striking distance of its all-time high, but a looming price war with Novo Nordisk and a dangerously concentrated revenue base raise real questions about how long the momentum holds.
The 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,478.22 over the next 12 months. Shares trade near $1,267.90 at noon, so the target means 16.6% upside. Our model rates Lilly a buy with 90% confidence.
24/7 Wall St. Price Target Summary
Metric
Value
Current Price
$1,267.90
24/7 Wall St. Price Target
$1,478.22
Upside
16.6%
Recommendation
BUY
Confidence Level
90%
That confidence reflects earnings momentum few mega-caps can match. Lilly has beaten EPS estimates for five straight quarters, raised full-year guidance, and holds the next major obesity catalyst in retatrutide. The incretin business should carry earnings well into 2027, according to the model.
Lilly Rallies Toward Its 52-Week High After Another Guidance Raise
Lilly gained 4.89% in today’s session after healthcare stocks including Lilly, Merck and AbbVie rallied Wednesday. Shares are up 6.66% over a week, 11.39% over a month, 18.55% year to date and 57.07% over the past year. The stock sits 1.9% below its 52-week high of $1,292.65 and 62.8% above its low of $778.94.
In Q2, revenue rose 47.67% to $22.97 billion, beating the $20.69 billion estimate, while EPS of $8.38 exceeded the $6.58 forecast. Mounjaro sales grew 91% to $9.94 billion. Management raised 2026 revenue guidance to $85 billion to $87 billion.
Why Bulls See $1,700 Ahead
Retatrutide is the main catalyst, with a U.S. filing planned for Q1 2027. On the Q2 call, Lilly’s CEO said, “We have a pretty large lead over any competitors with a triple acting medicine.” The oral GLP-1 Foundayo grew from about 8,000 to 36,000 prescribers, and the Medicare GLP-1 Bridge Program opened coverage to 20 million eligible Americans.
Wall Street agrees: 25 analysts rate the stock a buy or strong buy, with a consensus target of $1,330.14. Jim Cramer said in June he is “sticking with Lilly for the long haul.” Our bull case reaches $1,699.82, or 34.1% upside.
Pricing Pressure Is the Risk to Respect
Realized prices fell 13% in Q2, and Novo Nordisk (NYSE:NVO) plans to cut Wegovy’s list price by about 50% starting January 1, 2027. Mounjaro and Zepbound produced $14.9 billion of Q2 revenue, a heavy concentration, and guidance excludes pharma tariffs.
Volume growth of 60% more than covered the price cuts, though. The $2.78 billion in acquired R&D charges reflect pipeline spending that won’t repeat. The bear case of $1,245.07 sits only 1.8% below today’s price.
Lilly Outgrows Novo Nordisk and Pfizer by a Wide Margin
Novo Nordisk is Lilly’s direct GLP-1 rival. Its Q2 adjusted sales grew just 7% at constant currency, and it still guides to a 2026 decline of 0% to 6%. That gap explains why investors pay up for Lilly.
Pfizer (NYSE:PFE) shows the valuation trade-off. It trades at a P/E of about 21, compared with Lilly’s trailing 40 and forward 24. Pfizer’s revenue grew only 2.6%, however, as COVID sales faded.
Company
Latest Quarterly Revenue Growth
Operating Margin
Eli Lilly
47.67%
54.2%
Novo Nordisk
7% (adjusted, CER)
41.3%
Pfizer
2.6%
24.7%
Lilly’s forward multiple sits only a few turns above Pfizer’s P/E, even though Lilly is growing far faster. Against that background, our 24/7 Wall St. price target looks reasonable.
Lilly’s Growth Justifies the Premium
The 24/7 Wall St. price target of $1,478.22 carries a buy rating at 90% confidence. What tips the scale is volume growth outpacing price cuts.
The bull case strengthens if retatrutide’s filing stays on schedule and Foundayo keeps gaining share. The outlook weakens if realized prices drop faster after Novo’s 2027 list-price cuts. For now, Lilly’s earnings support a higher stock price.
Eli Lilly Price Prediction 2026-2030
The model projects where Lilly could trade if current growth trends and market conditions hold.
Target Date
Base Case
Bull Case
December 2026
$1,243.28
$1,284.43
October 2027
$1,478.89
$1,591.40
October 2028
$1,713.01
$1,937.42
October 2029
$1,894.05
$2,231.53
October 2030
$2,074.95
$2,492.66
Lilly would need to keep executing on its incretin strategy for these projections to hold. Retatrutide’s approval timing and U.S. drug-pricing policy could move results sharply in either direction from these tracks.
Contact [email protected] for any questions or corrections.
Stryker investuje přibližně 400 milionů USD do CMR Surgical, získá výhradní práva k prodeji systému Versius v USA a výhradní opci na akvizici zbývajícího vlastního kapitálu společnosti.
Key Takeaways Stryker enters soft-tissue robotics with a $400 million investment and exclusive U.S. Versius sales rights.The deal gives Stryker an exclusive option to acquire CMR Surgical and expand its robotic surgery portfolio.Versius' modular design offers operating room flexibility, while the investment supports global expansion. Stryker (SYK - Free Report) recently announced a strategic alliance with CMR Surgical, a global robotics company, to advance robotic-assisted surgery through an approximately $400 million (£300 million) preferred equity investment. The agreement grants Stryker an exclusive option to acquire the remaining equity of CMR Surgical in the future and makes it the exclusive U.S. sales agent for CMR Surgical’s Versius robotic surgery portfolio.
The move represents a strategic expansion into soft-tissue robotic-assisted surgery, combining CMR Surgical's established technology and clinical experience with Stryker's commercial reach and relationships with healthcare providers.
SYK Is Expanding Into Soft-Tissue Robotic SurgeryThe alliance provides Stryker with an opportunity to enter a growing segment of surgical robotics through an established platform. CMR Surgical’s second-generation Versius robotic platform has clinical experience globally and supports a broad range of soft-tissue surgical applications.
Designed for real-world operating environments, the Versius robot features a modular architecture intended to provide flexibility across surgical specialties, operating rooms and sites of care. Its configuration allows hospitals and ambulatory surgery centers (ASCs) to integrate robotic-assisted surgery into existing operating room workflows while maintaining operational flexibility.
According to Andy Pierce, group president of MedSurg and Neurotechnology at Stryker, soft-tissue robotics represents a natural extension of the company’s strengths in endoscopy, visualization and enabling technologies. The collaboration is expected to support broader adoption of robotic-assisted surgery across hospitals and ASCs.
Investment Supports Innovation and Global ExpansionStryker's approximately $400 million preferred equity investment is intended to support further product innovation and the global commercialization of Versius. Under the agreement, CMR Surgical will continue to lead product development and commercialization outside the United States, while Stryker will focus on U.S. sales. This arrangement allows both companies to contribute their respective strengths while pursuing broader international adoption.
The exclusive acquisition option is another important component of the agreement. It gives Stryker the opportunity to acquire 100% of CMR Surgical's outstanding equity in the future, subject to the agreement's terms. If exercised, the option could provide Stryker with greater control over the Versius platform and its long-term development.
Strategic ImplicationsThe alliance strengthens Stryker's position in surgical robotics, a market in which established medical technology companies are competing to provide more comprehensive solutions for surgeons and healthcare systems. While its Mako robotic platform has established a strong presence in orthopedic surgery, the addition of the Versius portfolio offers an opportunity to diversify into the growing soft-tissue robotics market.
For CMR Surgical, Stryker's investment and U.S. commercial support could improve its ability to compete against larger, established robotics companies. Versius' modular design may appeal to providers seeking flexibility in operating room configuration and a practical pathway to expanding robotic surgery. Commercial success will depend on clinical adoption, procedure volumes, hospital purchasing decisions, and the ability to demonstrate operational and economic benefits.
Peers in the Surgical Robotics SpaceMedtech leaders and specialized robotics companies like Intuitive Surgical (ISRG - Free Report) , Medtronic (MDT - Free Report) and Johnson & Johnson (JNJ - Free Report) are expanding their robotic platforms to improve surgical precision, workflow efficiency and access to minimally invasive procedures.
Intuitive Surgical maintains a strong position in robotic-assisted surgery through its da Vinci surgical systems. Its latest generation, the da Vinci 5 platform, incorporates more than 150 design innovations, including Force Feedback technology, enhanced 3D visualization, improved ergonomics and advanced data analytics. The platform is designed to improve surgeon control, streamline operating room workflows and support personalized surgical training. Its established installed base and recurring revenues from instruments, accessories and services provide a strong competitive advantage. Intuitive Surgical also offers the da Vinci SP system for single-port surgical procedures, expanding its minimally invasive surgery portfolio.
Medtronic is another major competitor through its Hugo robotic-assisted surgery system, which targets soft-tissue procedures. The modular platform combines wristed instruments, 3D visualization and digital capabilities supported by the Touch Surgery ecosystem. In December 2025, Medtronic received FDA clearance for Hugo in urologic procedures in the United States. The company pursued expanded indications in general and gynecologic surgery. Its September 2026 FDA clearance for the LigaSure RAS Maryland instrument further strengthens the platform’s surgical capabilities.
Johnson & Johnson is advancing its surgical robotics strategy through its Ottava robotic surgical system, alongside its broader Ethicon surgical instruments and technologies business. In July 2026, the company received FDA De Novo authorization for multiple upper-abdominal general surgery procedures. OTTAVA features a table-integrated robotic architecture designed to optimize operating room space, facilitate surgical team access and improve procedural workflows. Johnson & Johnson is seeking to combine robotic capabilities with its surgical portfolio and global relationships with healthcare providers to support greater adoption of robotic-assisted procedures across healthcare settings.
The market expects Nucor (NUE - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 26. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis steel company is expected to post quarterly earnings of $5.71 per share in its upcoming report, which represents a year-over-year change of +117.1%.
Revenues are expected to be $10.53 billion, up 23.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 9.11% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Nucor?For Nucor, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.
On the other hand, the stock currently carries a Zacks Rank of #1.
So, this combination makes it difficult to conclusively predict that Nucor will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Nucor would post earnings of $4.57 per share when it actually produced earnings of $4.84, delivering a surprise of +5.91%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Nucor doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Akcie společnosti Lam Research (LRCX) tento měsíc klesly o 40 % z maxima dosaženého v tomto roce na 263 USD; podle Wyckoffovy analýzy jim hrozí pokles k 200 USD.
Semicap equipment basket — buy the relative strength
Buy the semicap equipment peer that holds up best versus LRCX (e.g., ASML or Applied Materials, depending on current relative strength). The thesis is that LRCX’s Wyckoff breakdown is company-specific, while the broader capex/AI cycle still supports the group; you want exposure to the theme without the specific distribution risk.
Key Risk: The whole equipment complex breaks together (capex cuts or AI demand disappointment), dragging the peer down with LRCX.
Lam Research (LRCX) — sell
Sell LRCX. Despite strong fundamentals, the article flags a Wyckoff shift from markup into markdown/distribution, with the stock already down ~40% from its high. That pattern often keeps pressure on until a clear bottom forms, so you fade the “earnings will be great” narrative into the next leg down (possible retest toward ~$200).
Key Risk: Earnings/guidance and AI demand re-accelerate enough to flip the chart back into accumulation, triggering a fast short-covering rally.
Lam Research stock has been in a strong freefall this month. It dropped to $263, its lowest level since July 29, and 40% below its highest point this year. This sell-off may continue this week as jitters surrounding the artificial intelligence continues and as it publishes its financial results.
Lam Research is a top company in the semiconductor industry that manufactures equipment used in the chip-making industry. It focuses on areas like etching, deposition, cleaning and stripping, and advanced packaging.
Its technology is widely used in the making of DRAM, NAND, high-bandwidth memory and logic chips. As a result, it counts companies like Samsung Electronics, SK Hynix, Micron Technologies, and TSMC as its biggest customers.
As such, since these companies are seeing strong revenue growth, chances are that its revenue growth continued soaring in the third quarter. The most recent results showed that its revenue soared to $6.7 billion from $5.8 billion in the March quarter. Its gross margin continued rising, reaching 51.7%.
Most of its revenue was from Taiwan, followed by China, South Korea, and Japan. While it is an American company, the US revenue accounted for just 9% of its total sales, a notable thing since the US has a small market share in chip manufacturing.
Wall Street analysts are highly optimistic about the company’s growth. The average estimate is that its third-quarter revenue rose to $8.13 billion, up by 52% from the same period last year.
This growth will be followed by another 59% jump in Q4 to $8.52 billion. If this is correct, its annual growth rate will be 50% to $34.2 billion. Chances are high that Lam Research’s revenue will be higher than expected. Indeed, Morgan Stanley analysts predicted that the company’s guidance for the fourth quarter will be $9 billion.
Analysts are bullish on Lam Research, pointing to its strong revenue and profitability growth and its market share in the industry. Morgan Stanley recently hiked its target from $367 to $385, while Fundamental Research and B. Riley boosted it to $390. Berenberg analysts predict that the stock will hit $420, while UBS has a target of $425.
The general view is that its revenue and profits will justify its valuation, which has moderated a bit recently. Its forward price-to-earnings ratio stands at 27, slightly higher than the five-year average of 25.
LRCX stock chart | Source: TradingView
The daily chart shows that the LRCX stock remained in a narrow range for several years. This consolidation was part of the accumulation phase of the Wyckoff Theory. It then moved to the markup phase starting from early this year. This phase is usually characterized by higher demand from investors and speculators.
Now, there are signs that the stock has moved to the markdown and distribution phases. Therefore, there is a risk that Lam Research will continue falling, potentially to the psychological level of $200, down by 24% from the current level.
Workday spustil řešení AI Decision Intelligence, které propojuje personální a finanční data v reálném čase a umožňuje týmům HR a financí rychlejší rozhodování.
Key Takeaways WDAY launches Workday Decision Intelligence to unify workforce and financial data for faster decisions.The platform helps HR and finance teams analyze costs, risks, margins and forecasts in real time.Scenario analysis, approval workflows and insights from past decisions help improve planning and efficiency.
Workday, Inc. (WDAY - Free Report) has introduced Decision Intelligence, an artificial intelligence (AI)-powered solution that helps HR and finance teams evaluate workforce and financial decisions through a unified platform. The solution aims to reduce reliance on spreadsheets and disconnected systems by providing secure access to real-time enterprise data, helping businesses make faster, more informed decisions.
Workday Decision Intelligence enables users to ask questions in simple language, analyze business performance, compare options and take action securely. HR teams can use it to plan hiring, identify skills gaps and improve employee retention while assessing costs and risks. Finance teams can track revenue changes, profit margins, expenses and forecast variances to make better decisions.
The platform also enables organizations to evaluate business scenarios and route recommendations through established approval processes. By reviewing previous decisions, teams can identify effective strategies and improve future planning. Unity Technologies has reported benefits from using the solution to investigate revenue variances and streamline financial reporting.
With this expansion, Workday reinforces its focus on AI-powered business solutions. By combining workforce and financial data, the company aims to help businesses compare options, improve efficiency and respond faster to changing business needs.
Workday’s PeersFortinet, Inc. (FTNT - Free Report) is incorporating AI into its enterprise security solutions to help businesses monitor networks and respond to potential threats. Its technology combines AI-driven analysis with automated security tools, helping companies to manage risks and protect their digital infrastructure. Fortinet continues to develop intelligent security solutions as businesses face increasingly complex technology challenges.
Snap Inc. (SNAP - Free Report) is leveraging AI to make its digital platforms more engaging and improve advertising performance. The company uses AI to personalize content, enhance augmented reality features and help advertisers reach relevant audiences. These capabilities support Snap’s efforts to improve user engagement and create new opportunities in digital advertising.
Palo Alto Networks, Inc. (PANW - Free Report) is applying AI to simplify enterprise operations and help businesses make better use of their data. Its AI-powered capabilities support workflow automation, data analysis and more efficient business process management. Palo Alto Networks is expanding these solutions to help enterprises reduce manual work and improve productivity.
Published in artificial-intelligence cloud-computing tech-stocks
Key Takeaways CME Group's Q3 earnings are expected to rise 11.2%, with revenues projected to grow 11.4% year over year.CME Group's Q3 average daily volume rose 16% to 29.4 million contracts, driven by robust trading activity.CME's clearing fees are projected to rise 11%, while market data revenues are expected to increase 16.7%.
CME Group Inc. (CME - Free Report) is expected to register an improvement in both top and bottom lines when it reports third-quarter 2026 results on Oct. 21, before the opening bell.
The Zacks Consensus Estimate for CME’s third-quarter revenues is pegged at $1.71 billion, indicating an 11.4% increase from the year-ago reported figure.
The consensus estimate for earnings is pegged at $2.98 per share. The Zacks Consensus Estimate for CME’s third-quarter earnings has moved 2 cents north in the past seven days. The estimate suggests a year-over-year increase of 11.2%.
What the Zacks Model SaysOur proven model predicts an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), which increases the chances of an earnings beat.
Earnings ESP: CME Group has an Earnings ESP of +0.73%. This is because the Most Accurate Estimate of $3.00 is pegged higher than the Zacks Consensus Estimate of $2.98. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Factors Likely to Shape Q3 ResultsCME Group’s third-quarter results are likely to benefit from solid trading activity across its major asset classes, driven by interest-rate uncertainty, fluctuations in equity markets, commodity price volatility and growing demand for risk-management products.
Revenue growth is likely to have been aided by gains in market data and information services, as well as higher clearing, transaction and other fee-based income.
Increased volatility across asset classes appears to have boosted trading volumes, which, in turn, supported clearing and transaction fees. The Zacks Consensus Estimate for clearing and transaction fees stands at $1.4 billion, indicating an 11% increase from the same period last year.
CME Group reported a quarterly average daily volume (ADV) of 29.4 million contracts in the third quarter, which increased 16% year over year. Trading activity increased across asset classes. Agricultural ADV of 2 million contracts in the third quarter of 2026 increased 18% from the prior-year period. Equity Index ADV of 87.7 million contracts increased 23% year over year.
Market data and information services revenues are likely to have benefited from pricing adjustments on certain products as well as increased demand and usage. The Zacks Consensus Estimate for this segment is pegged at $236.3 million, suggesting a 16.7% year-over-year increase.
On the cost side, expenses are expected to have risen during the quarter, primarily due to higher spending on employee compensation and benefits, along with increased investment in technology.
Other Stocks to ConsiderHere are three finance stocks you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat.
Cboe Global Markets, Inc. (CBOE - Free Report) has an Earnings ESP of +0.94% and carries a Zacks Rank #3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $3.41, indicating a year-over-year increase of 27.7%. CBOE’s earnings beat estimates in each of the last four reported quarters.
Nasdaq (NDAQ - Free Report) has an Earnings ESP of +0.98% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $1.02, indicating a year-over-year increase of 15.9%. NDAQ’s earnings beat estimates in each of the last four reported quarters.
The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +3.38% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $6.91, indicating a year-over-year decrease of 38.1%. ALL’s earnings beat estimates in each of the last four reported quarters.
Arkham has reported more than 35 million labels on Robinhood Chain, saying its platform supports searches for every address, transfer, and transaction identifier on the Ethereum layer-2 network.
Summary
Arkham says Robinhood Chain has over 35 million labels, with searchable addresses, transfers, and transaction identifiers. Its tools support wallet tracking, entity analysis, and custom alerts for onchain activity. Arkham’s July 22 announcement confirms the integration predates its latest October post. Robinhood’s Stock Tokens remain unavailable to US persons under the company’s product restrictions. Arkham said in an Oct. 19 post that its labels, alerts and tracing tools are live on the chain. Its website dates an earlier integration announcement to July 22, when the company described support for tracking traders, monitoring transfers and accessing network data through its API.
Arkham’s Robinhood Chain support predates the latest post The October announcement puts a figure on Arkham’s labeling coverage while repeating the availability of its blockchain intelligence tools.
“We’re live on Robinhood Chain, bringing Arkham’s labels, alerts and tracing tools to Robinhood Chain,” the company wrote.
In its July announcement, Arkham described full endpoint integration for Robinhood Chain through its application programming interface. The company said calls available for other supported chains could be made for Robinhood Chain, alongside alerts for large fund movements and tools for following token prices.
By September, Arkham’s published research described the network as integrated into its multichain explorer. That article listed transaction searches, holder-concentration monitoring, and custom alerts for transfers, liquidity movements, and activity involving wallets or entities.
Neither the earlier announcement nor the supplied October post provides a matching Ethereum label count or a chain-by-chain coverage methodology. The 35 million figure remains Arkham’s reported total, without an independently established comparison of labeling depth between the two networks.
Robinhood Chain searches cover wallets and counterparties Arkham’s research describes several ways to examine activity beyond searching for a transaction identifier, commonly called a TXID.
According to the company, entering a Robinhood Chain address can display its historical balances, current portfolio, and leading counterparties. Its entity-clustering feature groups addresses attributed to a known entity so users can examine aggregate holdings.
The same research says users can trace transfers in real time and inspect specific payments or smart-contract executions through the platform’s search bar. Arkham presented those functions alongside examples of traders operating in the network’s memecoin markets.
Robinhood’s developer documentation separately lists Blockscout explorers for mainnet and testnet. It identifies Alchemy as its recommended infrastructure provider and directs developers seeking historical reads and indexing to archive endpoints available through infrastructure providers.
For network configuration, the documentation specifies mainnet chain ID 4663 and testnet chain ID 46630. Both use ETH as their currency, while Robinhood Chain uses Ethereum blobs for data availability.
The documentation distinguishes public endpoints from production infrastructure. Public endpoints are rate-limited, and Robinhood recommends a provider for production use. Developers can obtain standard transaction and account data through those services, while Arkham describes its offering through labels, entity groupings, portfolio views and alerts.
Tokenized stocks share the network with memecoin markets Robinhood launched the public mainnet on July 1, describing it as a permissionless layer 2 built using Arbitrum technology. Its launch announcement named Uniswap and Pleiades among the initial trading venues, with infrastructure integrations from Alchemy, BitGo, and Chainlink.
As crypto.news previously reported in its explanation of the network’s tokenized stock structure, Stock Tokens provide exposure to underlying equities while operating as transferable assets within supported onchain applications.
Trading developed around speculative tokens during the network’s first weeks. July 16 coverage of its early memecoin trading activity recorded roughly $312 million in total value locked and 3.6 million daily transactions. CASHCAT, an unaffiliated memecoin associated with Robinhood’s original working name, reached a market capitalization near $156 million.
By Sep. 2, coverage of RWA-linked trading volume cited a $390 million daily total from data compiled by onchain researcher Adam Tehc. Memecoin-stock pairs accounted for $217 million, while tokenized-stock trading contributed $127 million.
Those figures describe historical snapshots, rather than current October trading conditions. The September account described pools pairing memecoins with tokenized versions of companies including Nvidia, Tesla, Intel and Roblox.
Robinhood’s launch statement said eligible Stock Token holders could trade around the clock and use tokens in lending pools or as collateral across decentralized finance applications. Availability varied by jurisdiction, including for products accessed through Robinhood Wallet.
US Stock Token restrictions remain in Robinhood’s disclosures Robinhood’s support page distinguishes the public blockchain from its brokerage and crypto accounts. The company says Robinhood Chain operates independently of the main app and does not affect investments, crypto balances, or portfolios held there.
The same page identifies Robinhood Digital Assets, LLC as the chain’s provider and describes that entity as a software provider that does not offer regulated financial or advisory services.
In its product disclosures, Robinhood identifies Stock Tokens as tokenized debt securities issued by Robinhood Assets (Jersey) Limited. Holders receive economic exposure to underlying securities without legal or beneficial rights in the underlying issuer.
Robinhood says those Stock Tokens are not registered under US securities laws and cannot be offered, sold or delivered in the United States or to US persons. Its disclosures list further restrictions covering jurisdictions including Canada, the United Kingdom and Switzerland.
Polkadot byl podle Chainspect nejdražší sítí Layer 1: 100 000 transakcí za posledních sedm dní stálo více než 1 000 USD. Stejný objem transakcí na síti Sui, která byla v porovnání nejlevnější sítí Layer 1, stál 0,27 USD.
Chainspect data shows Polkadot (DOT) is the costliest Layer-1 for 100,000 transactions over seven days, while Sui (SUI) is the cheapest at $0.27.
Polkadot ($DOT) ranks as the most expensive Layer-1 blockchain to use, according to a fee comparison from analytics platform @chainspect_app. The data indicates that processing 100,000 transactions on @Polkadot cost more than $1,000 over the past seven days.
That puts the network at the top of the Layer-1 cost ranking. Other high-performance blockchains and rollup systems clear similar transaction volumes for a fraction of a cent per transaction. Sui (@SuiNetwork, $SUI) is the cheapest Layer 1 in the comparison, with 100,000 transactions costing $0.27.
Why Polkadot's Costs Look DifferentPolkadot's fee model helps explain how the figures can diverge from the network's usual reputation. According to the project's developer documentation, transaction fees on Polkadot are built from a base fee, a length fee and a weight fee, with an optional tip to prioritise inclusion. The weight fee reflects computational complexity, while the length fee scales with transaction size.
The architecture is also different from most Layer-1 networks. CoinShares describes Polkadot as a layer-0 network that connects multiple blockchains (parachains) under a shared security umbrella. Developers can use the Polkadot SDK to build their own chains and choose the fee model that suits them. That means costs on the relay chain are not necessarily representative of costs across the wider ecosystem.
Usage on the relay chain is also light. Chainspect's Polkadot page shows just 63 transactions in a one-hour window and an average transaction fee of about $0.0096. With so little activity, per-transaction cost comparisons can swing sharply depending on the period measured and the fee methodology used.
What It Means for DOTA high cost per 100,000 transactions does not by itself show that Polkadot is expensive for typical users, and the result depends on how Chainspect calculates fees over the seven-day window. Still, the ranking highlights a gap between Polkadot's interoperability-focused design and chains built for low-cost, high-volume activity such as Sui. Investors tracking $DOT and developers choosing a base layer may want to compare fee data across several time periods before drawing conclusions.
Sui Network's year-to-date SUI buybacks have reached 915,800 tokens, funded by stablecoin yield and fees. Here is how the program works and what it means for supply.
@SuiNetwork has bought back 915,800 $SUI year-to-date, putting the program within reach of the 1 million token mark. The purchases are funded by protocol-earned stablecoin yield and execution-fee earnings, and are carried out continuously on the open market.
Onchain data shows total protocol earnings of $3.2 million so far in 2026. The earnings are driven by transaction execution density and treasury float income on the Move-based Layer-1 network.
How the Sui buyback mechanism worksThe program converts yield from dollar-based assets held in network reserves into daily spot purchases of $SUI. , according to the network's own buyback dashboard.
The yield largely comes from USDsui, the network's native stablecoin. , CoinDesk reported at launch.
The model links stablecoin growth to token demand. The network's dashboard currently lists .
Buybacks are not burnsUnlike a buyback-and-burn scheme, the program does not shrink supply.
The scale is also modest relative to the market. In an August analysis, AMBCrypto noted that . It concluded the program .
The total has grown steadily since then. by early September, so the latest figure of 915,800 $SUI marks continued accumulation. The pace depends on how much yield the reserves generate, which can vary with stablecoin float and usage.
Sui's reference gas price was also changed this year. , which shifts more of the revenue mix toward stablecoin yield.
SourcesSui Network Revenue & SUI Buybacks (Sui)
Sui's native USDsui stablecoin goes live (CoinDesk)
Sui Buybacks Return Purchased Tokens Without Cutting Total Supply (TokenPost)
Have you assessed how the international operations of FMC (FMC - Free Report) performed in the quarter ended September 2026? For this chemical producer, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects.
In the modern, closely-knit global economic landscape, the capacity of a business to access foreign markets is often a key determinant of its financial well-being and growth path. Investors now place great importance on grasping the extent of a company's dependence on international markets, as it sheds light on the firm's earnings stability, its skill in leveraging various economic cycles and its broad growth potential.
Being present in international markets serves as a counterbalance to domestic economic challenges while offering chances to engage with more rapidly evolving economies. However, this kind of diversification introduces challenges like currency fluctuations, geopolitical uncertainties and varying market trends.
Upon examining FMC's recent quarterly performance, we noticed several interesting patterns in the revenue generated from its international segments, which are commonly analyzed and observed by Wall Street experts.
The company's total revenue for the quarter amounted to $841.4 million, marking a decrease of 19.9% from the year-ago quarter. We will next turn our attention to dissecting FMC's international revenue to get a clearer picture of how significant its operations are outside its main base.
A Closer Look at FMC's Revenue Streams AbroadDuring the quarter, Europe/Middle East/Africa contributed $214.1 million in revenue, making up 25.5% of the total revenue. When compared to the consensus estimate of $227.69 million, this meant a surprise of -5.97%. Looking back, Europe/Middle East/Africa contributed $306.9 million, or 40.5%, in the previous quarter, and $260 million, or 24.8%, in the same quarter of the previous year.
Of the total revenue, $277.9 million came from Latin America during the last fiscal quarter, accounting for 33%. This represented a surprise of -3.09% as analysts had expected the region to contribute $286.77 million to the total revenue. In comparison, the region contributed $177 million, or 23.3%, and $310 million, or 29.5%, to total revenue in the previous and year-ago quarters, respectively.
Asia accounted for 15% of the company's total revenue during the quarter, translating to $126.3 million. Revenues from this region represented a surprise of +27.87%, with Wall Street analysts collectively expecting $98.78 million. When compared to the preceding quarter and the same quarter in the previous year, Asia contributed $77.1 million (10.2%) and $159 million (15.1%) to the total revenue, respectively.
Revenue Projections for Overseas MarketsIt is projected by analysts on Wall Street that FMC will post revenues of $868.01 million for the ongoing fiscal quarter, a decline of 9.7% from the year-ago quarter. The expected contributions from Europe/Middle East/Africa, Latin America and Asia to this revenue are 9.4%, 26.8%, and 6.2%, translating into $81.51 million, $232.5 million, and $53.83 million, respectively.
For the entire year, the company's total revenue is forecasted to be $3.54 billion, which is a reduction of 9% from the previous year. The revenue contributions from different regions are expected as follows: Europe/Middle East/Africa will contribute 21.8% ($771.67 million), Latin America 29.2% ($1.03 billion) and Asia 11.6% ($410.3 million) to the total revenue.
The Bottom LineThe dependency of FMC on global markets for its revenues presents a mix of potential gains and hazards. Thus, monitoring the trends in its overseas revenues can be a key indicator for predicting the firm's future performance.
In an era of growing international interdependencies and escalating geopolitical disputes, Wall Street analysts are vigilant in tracking these trends for businesses with a global reach, in order to refine their predictions of earnings. It should be noted, however, that a multitude of other elements, such as a company's domestic position, also play a significant role in shaping the earnings forecasts.
We at Zacks strongly focus on the dynamic earnings forecast of companies, given that empirical studies have demonstrated its potent impact on the immediate price movement of stocks. Invariably, there's a positive relationship -- upward earnings predictions often result in an increase in stock prices.
Our proprietary stock rating tool, the Zacks Rank, with its externally validated exceptional track record, harnesses the power of earnings estimate revisions to serve as a dependable measure for anticipating the short-term price trends of stocks.
At the moment, FMC has a Zacks Rank #5 (Strong Sell), signifying that it may underperform the overall market trend in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Examining the Latest Trends in FMC's Stock ValueOver the preceding four weeks, the stock's value has diminished by 43.9%, against an upturn of 1.5% in the Zacks S&P 500 composite. In parallel, the Zacks Consumer Staples sector, which counts FMC among its entities, has appreciated by 3.6%. Over the past three months, the company's shares have seen a decline of 49.9% versus the S&P 500's 1.9% increase. The sector overall has witnessed an increase of 1.7% over the same period.
Bloom Energy ve 2. čtvrtletí 2026 vygenerovala volný peněžní tok ve výši 175 mil. USD, ale její akcie se obchodují za 347násobek zisku za posledních 12 měsíců.
While many fuel cell investors are still waiting for their investments to flourish, Bloom Energy (BE +3.51%) shareholders have enjoyed an impressive performance of late. Since the start of 2026, Bloom Energy shares have soared more than 166%.
But it's foolish to assume that simply because Bloom Energy shares have rocketed higher, the stock is a screaming buy. Let's take a closer look at both the good and the bad ahead of the company's reporting of its third-quarter 2026 financial results on Oct. 22.
Image source: Getty Images.
Generating steady free cash flow distinguishes Bloom from fuel cell peers
When evaluating the fundamentals of companies, investors can sometimes struggle to find any semblance of financial well-being. But that's hardly the case with Bloom Energy.
BE Revenue (Annual) data by YCharts.
From growing both revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) to maintaining a strong balance sheet (Bloom's net debt-to-EBITDA ratio was a conservative 0.35 at the end of Q2 2026), there are numerous indications of the company's impressive financial health. It's what's found on the cash-flow statement, however, that stands out as a bright, green flag.
Generating $175 million in free cash flow for Q2 2026, Bloom Energy has repeatedly produced free cash flow on a trailing-12-month basis for more than a year, proving that its ability to generate organic cash is more than a flash in the pan.
BE Free Cash Flow data by YCharts.
Plus, Bloom Energy's consistent free-cash-flow generation is uncommon among hydrogen-focused companies like Plug Power and FuelCell Energy, which have resorted to raising capital through substantial equity and debt issuances to keep the lights on.
Bloom stock's price tag may have some seeing red
In stellar financial health and with a significant market opportunity (Fortune Business Insights projects the fuel cell industry will grow from $16.8 billion in 2026 to $139 billion in 2034), Bloom Energy is certainly an alluring growth stock. The strong fundamentals, however, come at a cost.
Bloom Energy shares are currently changing hands at 347 times trailing earnings. As if its price-to-earnings (P/E) ratio wasn't steep enough, consider the steep cash-flow multiple: Bloom shares are priced at 109 times operating cash flow.
Because Bloom hasn't consistently generated earnings and positive operating cash flow for several years, it's impossible to compare the stock's current valuation to historical earnings-and cash-flow-based valuations. With respect to sales, though, investors can gain some insight. Trading at a notable premium to its five-year average sales multiple of 3.3, Bloom Energy's stock is changing hands today at 24.3 times trailing sales.
While the stock's valuation will surely deter value investors, those who don't typically prioritize bargain-bin stocks may also find the fuel cell stock's price tag prohibitive.
Should investors power their portfolios with Bloom Energy?
Since its initial public offering (IPO) in 2018, Bloom Energy has ascended into rarified air for hydrogen stocks, demonstrating both robust revenue and earnings growth, though the company's free-cash-flow production that is one of the most alluring qualities right now.
Although Bloom stock is pricey, it's not so pricey that those with multi-year investing horizons should look elsewhere to scratch their itch for quality growth stocks.
The trading week is just getting underway, and one of the most notable developments in the currency market has been the renewed strength of the Canadian dollar. This can be seen in the recent performance of USD/CAD, which has now declined for three consecutive sessions and is down approximately 1.0% over the period, highlighting the CAD's growing strength against the U.S. dollar.
For now, selling pressure around the pair remains relevant even after the release of Canadian inflation data. This is largely because the Canadian bond market has maintained relatively stable yields, helping to support demand for Canadian dollar-denominated assets. At the same time, the relationship between oil prices and the CAD has begun to regain importance in recent sessions. As long as these factors remain in place and the U.S. dollar continues to move through a corrective phase, selling pressure on USD/CAD could remain an important theme in the days ahead.
Canada Inflation Day Arrives
Canada's latest inflation figures were released during today's session. Overall, the main core inflation measures came in slightly below market expectations. The Trimmed CPI y/y, which excludes more volatile components, was reported at 1.8% versus an expected 1.9%, while Median CPI y/y, a measure used to track underlying inflation trends, came in at 1.9% compared to the 2.0% forecast.
However, annual CPI remains near 3.1%, highlighting that inflation pressures are still relatively elevated. Although some indicators came in below expectations, the data does not yet point to a sufficiently consistent slowdown that would justify a significantly more dovish stance from the Bank of Canada in the coming months. Current inflation levels also remain well above the lows seen in February, when annual CPI was close to 1.8%.
Source: TradingEconomics
This remains important because, even after the inflation release, Canadian 10-year government bond yields have shown little sign of weakness. Instead, yields continue to develop near the 4.0% area, maintaining a relatively stable environment that continues to support the attractiveness of Canadian dollar-denominated investments.
At the same time, U.S. dollar strength has begun to moderate. The DXY, which measures the dollar against its main peers, continues to trade near the 102-point area without being able to establish a sustained bullish trend. As a result, CAD has found room to recover part of the ground lost in previous weeks.
Source: TradingEconomics
Taking all of this into account, it is important to note that while inflation data did not surprise to the upside, it also failed to show a meaningful slowdown in price pressures. This has helped preserve stability in Canada's bond market and, combined with the recent loss of momentum in the U.S. dollar, has allowed the Canadian dollar to regain relevance in the short term. As long as this dynamic remains in place, selling pressure around USD/CAD could continue to be a dominant theme.
Is the Relationship with Oil Becoming Relevant Again?
Another important factor to consider is the close relationship between the Canadian economy and the energy sector. Canada remains one of the world's largest oil producers and exporters, meaning that significant moves in crude oil prices often have an important impact on demand for the Canadian dollar. As oil prices rise, export revenues tend to increase, supporting stronger capital inflows and helping strengthen the CAD in the short term.
Over recent sessions, this relationship has begun to regain relevance. The CXY, an index that measures the strength of the Canadian dollar, continues to advance while WTI crude oil maintains a bullish trend that has pushed prices increasingly closer to the $100 per barrel area.
The most interesting element emerges when looking at the short-term correlation between both markets. The correlation coefficient currently stands near 0.56, reflecting a meaningful positive relationship between recent movements in oil and the Canadian dollar. This suggests that rising crude prices may be providing additional support to CAD’s recent recovery. It is important to remember that correlation can change over time.
Source: TVC, StoneX, Tradingview
This relationship is particularly important because it had weakened during previous months. However, the recent strength in oil prices appears to be bringing it back into focus and may help explain part of the resilience currently being displayed by the Canadian dollar against the USD. As long as oil remains in an upward trend and the positive correlation persists, this factor could continue supporting downside pressure on USD/CAD in the coming sessions.
USD/CAD Technical Forecast
Source: StoneX, Tradingview
The bearish bias is regaining relevance: Although USD/CAD attempted to develop a short-term bullish trendline in recent weeks, that structure gradually lost momentum as price approached highs not seen for several months. A renewed bearish bias is now beginning to emerge on the chart. However, it is important to remember that a lack of direction remains a key characteristic of the market and, unless important support levels are broken, a broader period of consolidation could still develop over the coming weeks.
MACD: The MACD histogram continues to fluctuate very close to the 0 neutral line, reflecting a relatively balanced dynamic in short-term moving-average momentum. This reading continues to support the possibility that a phase of indecision remains relevant on the chart.
RSI: A similar picture can be observed in the RSI, which continues to trade near the 50 neutral level. This behavior reflects a relatively balanced momentum environment and suggests that the recent lack of direction remains an important feature of price action.
Key Levels:
1.42321 – Key Resistance: A major high observed over recent months and the most important upside barrier on the chart. A move back toward this level could restore relevance to the bullish bias and support a more consistent bullish structure.
1.41606 – Near-Term Barrier: A level that aligns with significant retracement zones observed several weeks ago and could become the main area to monitor in the event of short-term bullish corrections.
1.39959 – Critical Support: The last major support barrier on the daily chart and a level that coincides with the 50-period simple moving average. Sustained moves below this area could reinforce the bearish bias and open the door to a more established downtrend in the weeks ahead.
Written by Julian Pineda, CFA, CMT – Market Analyst
Wall Street analysts expect Norfolk Southern (NSC - Free Report) to post quarterly earnings of $3.48 per share in its upcoming report, which indicates a year-over-year increase of 5.5%. Revenues are expected to be $3.46 billion, up 11.6% from the year-ago quarter.
The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Norfolk Southern metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Railway operating revenues- Merchandise- Agriculture, forest and consumer products' of $700.42 million. The estimate points to a change of +11.2% from the year-ago quarter.
The consensus estimate for 'Railway operating revenues- Coal' stands at $417.75 million. The estimate indicates a year-over-year change of +11.4%.
The consensus among analysts is that 'Railway operating revenues- Merchandise- Chemicals' will reach $639.98 million. The estimate indicates a change of +12.5% from the prior-year quarter.
Analysts expect 'Railway operating revenues- Intermodal' to come in at $915.37 million. The estimate indicates a change of +20.6% from the prior-year quarter.
The combined assessment of analysts suggests that 'Railway Operating Ratio' will likely reach 66.1%. Compared to the present estimate, the company reported 64.6% in the same quarter last year.
According to the collective judgment of analysts, 'Revenue ton miles' should come in at 48.48 billion. The estimate compares to the year-ago value of 46.90 billion.
The average prediction of analysts places 'Carloads (Units) - Volume - Merchandise' at 611.45 thousand. Compared to the present estimate, the company reported 595.10 thousand in the same quarter last year.
Analysts predict that the 'Carloads (Units) - Volume - Intermodal' will reach 1.06 million. The estimate compares to the year-ago value of 1.03 million.
Analysts forecast 'Revenue per Carload (Unit) - Total' to reach $1891.03 . The estimate is in contrast to the year-ago figure of $1721.00 .
It is projected by analysts that the 'Revenue per Carload (Unit) - Coal' will reach $2294.84 . Compared to the present estimate, the company reported $2120.00 in the same quarter last year.
Based on the collective assessment of analysts, 'Revenue per Carload (Unit) - Merchandise' should arrive at $3545.47 . Compared to the current estimate, the company reported $3310.00 in the same quarter of the previous year.
Analysts' assessment points toward 'Revenue per Carload (Unit) - Intermodal' reaching $865.30 . Compared to the present estimate, the company reported $735.00 in the same quarter last year.
View all Key Company Metrics for Norfolk Southern here>>>
Shares of Norfolk Southern have experienced a change of +4.1% in the past month compared to the +1.5% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), NSC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
IonQ převezme Elisity v akciové transakci v hodnotě až 1,3 miliardy USD, aby rozšířil své kyberbezpečnostní schopnosti o technologie Zero Trust, PQC a QKD.
Key Takeaways IONQ will acquire Elisity in a deal valued at up to $1.3 billion to expand its cybersecurity platform.IONQ's acquisition combines its PQC and QKD capabilities with Elisity's enterprise Zero Trust technology.IONQ gains access to Elisity's 100 global customer deployments and the $10B microsegmentation market.
IonQ (IONQ - Free Report) recently announced a definitive agreement to acquire Elisity, Inc., a Zero Trust security company, in an all-stock transaction valued at up to $1.3 billion. The deal will combine IonQ's post-quantum cryptography (PQC) and quantum key distribution (QKD) capabilities with Elisity's enterprise Zero Trust technology to expand its cybersecurity platform and help uncover and protect against current LLM and emerging quantum threats. It will also add Elisity's high-growth enterprise security business and a team of industry leaders to IonQ.
Elisity has a strong track record of doubling its revenues and customer base year over year with zero churn among deployed customers. IonQ will gain expanded channels to market its PQC, QKD and quantum computing offerings to enterprise and government networks through Elisity’s more than 100 global customer deployments and strong relationships across the CISO and security communities. The acquisition provides IonQ with an entry into the microsegmentation market, a more than $10 billion opportunity with a double-digit CAGR.
According to IonQ’s chairman and CEO, the acquisition will enhance the company’s ability to secure critical infrastructure and enterprise networks throughout the transition to the quantum era, as Q-Day may arrive sooner than expected.
IonQ has deployed quantum-safe communications networks in several countries and offers security solutions spanning QKD and PQC. Its multiproduct revenues grew 40% year over year in the second quarter of 2026, reflecting increased adoption of multiple offerings. The Elisity acquisition is expected to create cross-selling opportunities and help IonQ expand its enterprise and government customer base.
The agreement price includes up to $150 million in earnout opportunity subject to performance of the Elisity business. The number of shares IonQ will issue will be based on its volume-weighted average stock price over the 20 trading days preceding the third business day before closing. The price used to calculate the share count will be capped at $49.61 per share, with a floor of $33.07.
Updates From IONQ PeersThis month, D-Wave Quantum Inc. (QBTS - Free Report) and the Supply Chain Management Research Center in the Sam M. Walton College of Business at the University of Arkansas (“SCMRC”) announced a collaboration to explore quantum computing’s impact on complex supply-chain problems. The partnership establishes the Quantum Supply Chain Initiative Support Fund with the SCMRC, meant to advance thought leadership, education and independent research focused on the application of quantum computing to supply-chain management across retail, transportation and national defense. D-Wave has also joined the SCMRC partnership program, which presently has more than 25 industry partners.
Quantum Computing Inc. (QUBT - Free Report) , or QCi, announced Dirac-3S, the next-generation of its Dirac-3 quantum optimization machine. Dirac-3S advances the platform across three areas — Speed, Scale and Solutions — with faster performance, improved solution quality, increased computing capacity and a modular architecture designed to support customers as their requirements grow. The development marks a significant step toward commercial deployment of QCi’s quantum optimization technology, with the first customer shipment of Dirac-3S expected in November 2026.
Comfort Systems USA ve 3. čtvrtletí očekává tržby ve výši 3,35 mld. USD a EPS 12,70 USD, což představuje meziroční růst o 36,7 %, respektive o 53,9 %, podpořený rekordním objemem zakázek ve výši 14,06 mld. USD.
Key Takeaways FIX's Q3 EPS is expected to jump 53.9%, with revenues projected to rise 36.7% year over year.A record $14.06B backlog and robust data center demand are expected to fuel Mechanical and Electrical growth.FIX's 54.2% year to date rally, 25.2X forward P/E and rising costs raise caution ahead of Q3 earnings.
Comfort Systems USA, Inc. (FIX - Free Report) is slated to report its third-quarter 2026 results on Oct. 22, after market close.
In the last reported quarter, the company’s earnings and revenues topped the Zacks Consensus Estimate by 20.7% and 11%, respectively. Adjusted earnings per share (EPS) of $12.53 surged 91.9% from the year-ago quarter. Revenues of $3.27 billion also rose 50.3% year over year. Operating cash flow reached $1.14 billion, while backlog climbed 73% year over year to a record $14.06 billion. Management remained optimistic about continued growth through 2026 and into 2027, supported by strong project pipelines and expanding modular capabilities.
FIX’s earnings topped the consensus mark in each of the trailing four quarters. The average surprise is shown in the chart below.
Image Source: Zacks Investment Research
How Are Estimates Placed for FIX Stock?The Zacks Consensus Estimate for third-quarter EPS has increased to $12.70 from $12.64 over the past 60 days. The estimate indicates 53.9% growth from the year-ago EPS of $8.25. The consensus mark for revenues is pegged at $3.35 billion, indicating a 36.7% year-over-year increase.
For 2026, Comfort Systems is expected to post a 42.1% increase in revenues from a year ago. Its EPS is expected to grow 67.6% from a year ago. Below is what to expect from FIX stock.
Comfort Systems EPS Estimate
Image Source: Zacks Investment Research
Comfort Systems Revenue Estimate
Image Source: Zacks Investment Research
Factors Likely to Have Defined FIX’s Q3 PerformanceStrong Backlog Likely Supported Revenues: Comfort Systems’ third-quarter 2026 revenues are expected to have benefited from sustained demand for data centers, technology infrastructure and mission-critical facilities. The company entered the quarter with a record backlog of $14.06 billion, providing strong revenue visibility. Continued investments in advanced manufacturing, healthcare, education and government projects are also likely to have supported activity. Management expects full-year 2026 same-store revenue growth in the mid- to high-30% range, indicating continued momentum.
Segment-Wise: Comfort Systems operates through two segments — Mechanical and Electrical.
The Mechanical segment (which accounted for 73.3% of total revenues in 2025) is expected to have benefited from demand for HVAC installations, piping systems and modular fabrication associated with hyperscale data centers and industrial facilities. Expanding modular production capacity and healthy project pipelines are likely to have supported revenues. The Zacks Consensus Estimate for the segment’s revenues is currently pegged at $2.35 billion for the third quarter, up from $1.81 billion reported a year ago.
The Electrical segment (which contributed 26.7% of total revenues in 2025), is expected to have benefited from rising demand for electrical infrastructure, power distribution and control systems across technology and industrial projects. Contributions from the Hunt Electric acquisition, expected to generate approximately $250 million in annualized revenues, should have further supported segmental growth. The Zacks Consensus Estimate for the segment’s revenues is currently pegged at $1.0 billion for the third quarter, up from $640.5 million reported a year ago.
Margins Likely Remained Strong: Third-quarter margins are expected to have benefited from favorable project execution, disciplined bidding, strong pricing and operating leverage. Management anticipates gross margins remaining within the healthy ranges achieved in recent quarters. However, higher workforce expenses and continued investments in modular manufacturing capacity could have partially offset margin gains.
Overall Earnings Expectations: Higher revenues, favorable project mix and operating efficiencies are likely to have supported earnings growth. Management did not provide specific third-quarter guidance but expressed confidence in sustained growth through 2026 and projected a full-year effective tax rate of approximately 23%.
What the Zacks Model Says for FIX StockOur proven model does not conclusively predict an earnings beat for Comfort Systems this time around. A combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.
FIX’s Earnings ESP: The company has an Earnings ESP of 0.00%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
FIX’s Zacks Rank: The company currently carries a Zacks Rank of 4 (Sell).
You can see the complete list of today’s Zacks #1 Rank stocks here.
FIX Stock’s Price PerformanceFIX stock has risen 54.2% year to date, outperforming the Zacks Building Products - Air Conditioner and Heating industry, the Zacks Construction sector and the S&P 500 Index.
FIX Stock’s Price Performance (Year to date)
Image Source: Zacks Investment Research
Comfort Systems operates at a critical level of the artificial intelligence (AI)-driven data center and technology infrastructure boom, competing with Quanta Services, Inc. (PWR - Free Report) , Carrier Global Corporation (CARR - Free Report) and EMCOR Group, Inc. (EME - Free Report) across distinct but overlapping markets. Year to date, FIX has outperformed these major industry peers, with Quanta, EMCOR and Carrier Global gaining 49.7%, 18% and 4.1%, respectively. This outperformance reflects investors’ confidence in Comfort Systems’ strong exposure to high-growth markets, particularly AI data centers, advanced manufacturing and mission-critical infrastructure.
FIX's Price Performance vs Peers (YTD)
Image Source: Zacks Investment Research
FIX’s Valuation TrendFIX stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 25.2, as evidenced by the chart below.
FIX’s Valuation vs Industry (P/E F12M)
Image Source: Zacks Investment Research
At 25.2X forward 12-month earnings, Comfort Systems trades above Carrier Global's 17.22X and EMCOR's 19.84X, suggesting that investors are willing to pay a higher multiple for its growth prospects, strong backlog and exposure to technology-related infrastructure spending. However, FIX remains relatively cheaper than Quanta, which commands a higher multiple of 33.5X. This valuation gap suggests that Comfort Systems offers comparatively more attractive pricing than Quanta, although its premium over Carrier Global and EMCOR leaves limited room for execution setbacks.
Should Investors Sell FIX Stock Before Q3 Earnings?Despite strong backlog growth and healthy demand from data centers and technology infrastructure, investors may consider selling FIX stock ahead of its third-quarter earnings release. The stock’s 54.2% year-to-date rally and premium valuation relative to Carrier Global and EMCOR suggest that much of its growth potential is already priced in. Rising labor costs, capacity expansion expenses and high investor expectations could increase downside risks if results disappoint. FIX’s Zacks Rank #4 reinforces near-term caution. Given these factors, booking profits ahead of the earnings announcement appears prudent.
Bank of Hawaii očekává za čtvrtletí EPS ve výši 1,52 USD (+26,7 % meziročně) a tržby 203,16 mil. USD (+11,2 %), avšak Earnings ESP je záporné a činí -2,17 %.
The market expects Bank of Hawaii (BOH - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on October 26, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis bank holding company is expected to post quarterly earnings of $1.52 per share in its upcoming report, which represents a year-over-year change of +26.7%.
Revenues are expected to be $203.16 million, up 11.2% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.79% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Bank of Hawaii?For Bank of Hawaii, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -2.17%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Bank of Hawaii will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Bank of Hawaii would post earnings of $1.46 per share when it actually produced earnings of $1.47, delivering a surprise of +0.68%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Bank of Hawaii doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAmong the stocks in the Zacks Banks - West industry, First Hawaiian (FHB - Free Report) , is soon expected to post earnings of $0.6 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +1.7%. This quarter's revenue is expected to be $229.71 million, up 1.5% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for First Hawaiian has been revised 7.5% up to the current level. Nevertheless, the company now has an Earnings ESP of 0.00%, reflecting an equal Most Accurate Estimate.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that First Hawaiian will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Wall Street analysts forecast that AppFolio (APPF - Free Report) will report quarterly earnings of $1.78 per share in its upcoming release, pointing to a year-over-year increase of 35.9%. It is anticipated that revenues will amount to $293.84 million, exhibiting an increase of 17.8% compared to the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some AppFolio metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenue- Other' reaching $1.93 million. The estimate points to a change of -45% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Value Added Services' at $230.99 million. The estimate suggests a change of +20.3% year over year.
The consensus estimate for 'Revenue- Subscription Services' stands at $62.40 million. The estimate indicates a year-over-year change of +16.1%.
View all Key Company Metrics for AppFolio here>>>
AppFolio shares have witnessed a change of -1.2% in the past month, in contrast to the Zacks S&P 500 composite's +1.5% move. With a Zacks Rank #2 (Buy), APPF is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Společnost Okta získala hodnocení Zacks Rank #2 (Koupit); pro aktuální čtvrtletí se očekává zisk na akcii (EPS) ve výši 0,93 USD, což představuje meziroční nárůst o 13,4 %.
Okta (OKTA - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this cloud identity management company have returned +2.7% over the past month versus the Zacks S&P 500 composite's +1.5% change. The Zacks Security industry, to which Okta belongs, has lost 5.4% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Okta is expected to post earnings of $0.93 per share for the current quarter, representing a year-over-year change of +13.4%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The consensus earnings estimate of $3.93 for the current fiscal year indicates a year-over-year change of +12.3%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $4.44 indicates a change of +13% from what Okta is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Okta.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Okta, the consensus sales estimate of $815.52 million for the current quarter points to a year-over-year change of +9.9%. The $3.22 billion and $3.55 billion estimates for the current and next fiscal years indicate changes of +10.4% and +10.1%, respectively.
Last Reported Results and Surprise HistoryOkta reported revenues of $805 million in the last reported quarter, representing a year-over-year change of +10.6%. EPS of $1.05 for the same period compares with $0.91 a year ago.
Compared to the Zacks Consensus Estimate of $792.14 million, the reported revenues represent a surprise of +1.62%. The EPS surprise was +9.38%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Okta is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Okta. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
Cadence Design Systems očekává za čtvrtletí zisk 2,04 USD na akcii a tržby ve výši 1,61 miliardy USD, což představuje meziroční nárůst o 5,7 % a 20,3 %.
The market expects Cadence Design Systems (CDNS - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 26. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis maker of hardware and software products for validating chip designs is expected to post quarterly earnings of $2.04 per share in its upcoming report, which represents a year-over-year change of +5.7%.
Revenues are expected to be $1.61 billion, up 20.3% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.85% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Cadence?For Cadence, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.56%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination indicates that Cadence will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Cadence would post earnings of $2.05 per share when it actually produced earnings of $2.11, delivering a surprise of +2.93%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Cadence appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Marvell Technology shed 17% in a single week after one of the strongest runs in the AI trade, and that gap between the selloff and the business fundamentals is exactly what makes the timing interesting right now.
AI investors have reason to track Marvell Technology (NASDAQ:MRVL | MRVL Price Prediction), and last week brought a sharp decline. Shares fell 17.24% in the week ended October 16 to $227.83, after a 168.54% year-to-date run. The next earnings report will show how fast the business is moving.
Why Marvell Sits at the Center of AI Networking
Marvell builds parts that let AI chips talk. These include optical DSPs, Ethernet switches, and custom silicon designed alongside hyperscalers. Clusters keep getting bigger, and every bigger cluster needs more bandwidth. Management addressed bandwidth needs for these multi-site networks.
The needs are projected to be more than 10 times greater than current front-end networks. Marvell sells that connectivity. It is one of several suppliers we profiled in a free report on the companies powering the AI buildout outside the chipmakers.
Three Data Points Driving Marvell’s Growth Case
First, growth is speeding up. Data Center revenue grew 21% in Q4 FY2026, then 27%, then 46% last quarter. Management guided Q3 Data Center growth to roughly 75% year-over-year on total revenue of $3.150 billion. Fiscal 2027 revenue should reach roughly $12 billion.
Second, the deal with Alphabet (NASDAQ:GOOGL) unit Google changes how big the custom business can get. Marvell granted a warrant letting Google acquire up to 7% of its shares, tied to revenue targets. Custom revenue should more than double year over year in fiscal 2028. When an analyst cited a $120 billion cumulative revenue opportunity over six years, management replied, “your math is not wrong.”
Third, margins are expanding. Non-GAAP operating margin rose to 36.6% from 34.8%, and management expects to enter its 38% to 40% target range in Q4. Q3 non-GAAP EPS guidance of $1.10 compares with $0.94 last quarter.
How Marvell Stacks Up Against NVIDIA and AMD
While NVIDIA (NASDAQ:NVDA) dominates AI, its financing exposure keeps growing. Supply commitments reached $279 billion, guarantees for AI cloud partners are limited at $108.5 billion, and days sales outstanding rose to 60 days from 45 days on extended payment terms. If credit tightens for AI builders, Marvell’s biggest partner is Google, a company that designs and pays for its own chips.
Advanced Micro Devices (NASDAQ:AMD) trades at a P/E of about 199, and its non-GAAP operating margin of 27% trails Marvell’s. Data Center makes up only 58% of AMD’s revenue, so AMD offers less focused exposure to the AI expansion.
Risks That Could Derail Marvell’s Run
Concentration concerns me. Data Center now makes up 79% of revenue, a few customers drive much of it, and any hyperscaler could bring more chip design in-house. Chinese trade restrictions and $4.963B of debt due in future years add risk. The stock also swings hard: it fell 10.28% on the day it reported a beat in August.
A strong balance sheet protects against those risks. Net debt runs just 0.27 times EBITDA. The Google warrant gives Marvell’s largest partner a stake in keeping the relationship going. Over the last seven quarters, Marvell reported six beats and no misses.
What to Watch as Marvell’s AI Business Scales
The quarterly dividend is only $0.06, so Marvell offers little for income-focused investors and stands primarily as a growth story. Buybacks of $2.0401B in fiscal 2026 returned capital to shareholders. With Data Center growth expected to top 60% in fiscal 2028, investors will watch whether bookings and margins keep pace with that outlook.
Contact [email protected] for any questions or corrections.
Společnost Brown & Brown před zveřejněním výsledků za čtvrtletí končící v září 2026 očekává zisk 1,08 USD na akcii a tržby ve výši 1,76 mld. USD; ukazatel Earnings ESP činí +1,62 %.
The market expects Brown & Brown (BRO - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 26. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis insurance company is expected to post quarterly earnings of $1.08 per share in its upcoming report, which represents a year-over-year change of +2.9%.
Revenues are expected to be $1.76 billion, up 9.9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.06% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Brown & Brown?For Brown & Brown, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.62%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Brown & Brown will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Brown & Brown would post earnings of $1.08 per share when it actually produced earnings of $1.07, delivering a surprise of -0.93%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Brown & Brown appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
